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Nature provides the inspiration for fabrication of materials. Biological materials are 
highly organized from molecular to macro scales, and make different functional 
parts, such as hard and soft tissues. In hard tissues, bones, dental tissues, spicules, 
shells, bacterial nanoparticles are examples of hybrid materials with proteinaous and 
inorganic layer formed together. Therefore, peptide and proteins can be utilized as 
versatile building block is fabricating materials. Traditionally, large proteins have 
been used in engineering, mostly to increase biocompatibility of implants, surface 
coating, and making molecular scaffolds for use in tissue engineering. Additionally, 
the integration of proteins with signal transducers, protein-based biosensors, has 
exceedingly been utilized in many technologies including medical diagnostics. 
The current binding and assembly of biomolecules onto solid substrates for various 
sensing applications are predominantly accomplished using covalently bound 
chemical linkers, e.g. thiols and silane linkers. For chemo- and bio-sensing 
applications, nevertheless, more biology-friendly linkers are necessary that are both 
versatile and amenable to genetic manipulation. A novel alternative to current 
chemical coupling may be through the utility of combinatorial inorganic-binding 
peptides as specific molecular linkers. Phage and cell surface display have become 
the major in vivo techniques for the selection of material-specific peptides, called 
genetically engineered peptides for inorganics, GEPI. After display techniques 
selected inorganic binding peptides can be further modified, engineered through 
genetic engineering methods and synthesized to utilize as molecular tools with 
controlled functionalities. To provide new functionality to inorganic binding 
peptides, bi-functional proteins can be generated with functional proteins such as 
enzymes and GEPI through genetic engineering. 
GEPI can be used alone or as a fusion partner in functional proteins. Therefore, the 
methods to produce them via recombinant DNA technology and to check their 
inorganic binding functionality once they are inserted into different protein domains, 
is crucial. We aim to develop a recombinant production method for GEPI as a fusion 
partner in maltose binding protein (MBP). Two main objectives of this study are 
genetic engineering and purification of MBP-GEPI bi-functional protein in order to 
demonstrate applicability of the proposed method. To demonstrate this, we selected 
two GEPIs to produce as fusion partners, namely gold binding peptide (AuBP1,) and 
quartz binding peptide (QBP2). We also used two different peptide linkers as S(G)3  
and (PG)3 between MBP and GEPI in the expression to test the effect of linkers in bi-
functional activities of the fusion constructs. For the expression of the proteins, 
pMAL expression and purification system was used. The vectors, pMALc2X, were 
constructed, and bi-functional proteins were expressed in Luria Bertani medium and 
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BIONANOTECHNOLOGY 
SUMMARY 
  
xviii
purified by amylose affinity chromatography. Purification of the bi-functional 
protein has been then optimized and the mass of resulting protein has been confirmed 
by mass spectrometry. We believe these constructs will lead to new facile 
alternatives in the formation of protein-metal and protein-metal oxide biosensors and 
bioassays. Moreover, the genetically designed bi-functional proteins can be used to 
create different material architectures in biomedical fields and nano-electronics due 
to gold and quartz binding peptide features. 
 
 
 
  
xix
Doğa malzemelerin üretiminde ilham kaynağıdır. Biyolojik malzemeler, moleküler 
boyuttan makro boyuta yüksek derecede organizasyona sahiptirler ve yumuşak ve 
sert dokular gibi fonksiyonel kısımlardan oluşurlar. Sert dokulardaki, protein ve 
anorganik katmanın birlikte oluşturduğu melez malzemelere örnekler, kemikler, diş 
dokuları, spiküller, deniz kabukları ve bakteriyel nano parçacıklardır.  Bu nedenle, 
peptid ve proteinler malzemelerin üretiminde çok yönlü yapı taşları olarak 
kullanılabilir. Buna ek olarak, proteinlerin sinyal dönüştürücüler ile 
tümleştirilmesiyle oluşturulan proteine dayalı biyo duyargalar tıbbi tanıları da 
kapsayan pek çok teknolojik alanda kullanılmaktadır. 
Günümüzde çeşitli duyarga uygulamalarında kullanılmakta olan biyomoleküllerin 
katı bir tabakanın yüzeyine bağlanması ve montajı çoğunlukla kovalent bağ oluşturan  
tiyol ve silan bağlayıcılar gibi kimyasal bağlayıcılarla gerçekleşmektedir.  Kimyasal 
ve biyolojik duyarga uygulamaları için, ne yazık ki, hem çok yönlü hem de genetik 
değişikliklere uygun olan daha çok biyolojik açıdan elverişli bağlayıcılara 
gereksinim vardır. Anorganiklere bağlanan  peptidlerin spesifik moleküler bağlayacı 
olarak kullanılması günümüzdeki kimyasal bağlamaya yeni bir alternatif olabilir. 
GEPI diye adlandırılan genetik olarak üretilmiş peptidlerin malzemeye spesifik 
seçilmesinde kullanılan faj ve hücre yüzey gösterimi in vivo tekniklerin başında 
gelmektedir. Gösterim teknikleriyle seçilmiş anorganik bağlayıcı peptidler, genetik 
mühendisliği yöntemleriyle daha da geliştirilip, değiştirilebilir ve kontrol edilebilir 
işlevsellik kazandırılarak moleküler araç olarak kullanılmak üzere üretilebilirler. 
Anorganik bağlayıcı peptidlerle genetik mühendisliği yöntemleri kullanılarak enzim 
gibi proteinlerle birleştirilip çift işlevli proteinler oluşturulabilir. 
GEPI tek başına kullanılabileceği gibi fonsiyonel proteinlerin füzyon kısmı olarak da 
kullanılabilir. Bu sebeple, GEPI’yi rekombinant DNA teknolojisi ile üretmek ve 
farklı proreinlerle birleştirildiğinde anorganik bağlama işlevinin kontrolünü yapmak 
için gerekli olan yöntemler çok önemlidir.  Bu çalışmada, GEPI’nin maltoz bağlayan 
proteinde (MBP) füzyon kısım olarak davranacağı bir rekombinant üretim yöntemi 
geliştirmeyi amaçladık. Bu çalışmadaki iki ana hedef, ileri sürülen yöntemin 
uygulanabilirliğini göstermek için MBP-GEPI çift işlevli proteinin genetik 
mühendisliği ve saflaştırlmasıdır. Bunu göstermek için füzyon kısım olarak 
kullanacağımız altına bağlanan peptid diye adlandırılan AuBP1 ve silikaya bağlanan 
peptid olarak bilinen QBP2 seçildi. Aynı zamanda füzyon yapılarin çift işlevli 
aktivitelerinde bağlayıcıların etkinliğini kontrol etmek için MBP ve GEPI arasına 
S(G)3 ve (PG) gibi iki farklı peptid bağlayıcı yerleştirildi. Proteinlerin üretilmesinde 
ise pMAL ekspresyon ve saflaştırma sisteminden faydalanıldı. pMALc2X vektörleri 
oluşturulup Luria Bertani besiyerinde ilgili proteinler üretilerek amiloz ilgi 
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kromatografisi ile saflaştırıldı. Çift işlevli proteinlerin saflaştırılması optimize 
edildikten sonra proteinlerin moleküler ağırlıkları kütle spektrometresiyle 
doğrulandı. Bu yapıların, protein-metal ve protein-metal oksit biyoduyarga ve 
biyoanalizlerin oluşumunda yeni alternatiflere öncü olacaklarına inanılmaktadır. 
Dahası genetik olarak tasarlanmış çift işlevli proteinler biyomedikal alanda ve 
nanoelektronikte altına ve kuvartza bağlanma özelliklerinden dolayı farklı 
malzemelerin inşasında da kullanılabilecektir. 
 
 
 
 
  
  
1 
The ability to synthesize and manipulate material at the nanometer length scales can 
have significant impact in different fields, including microelectronics, computation, 
therapeutics, and diagnostics [1,2]. A wide number of inorganic nanoparticles 
including carbon nanotubes, buckyball fullerenes and various semiconductor and 
metal nanoparticles have long been utilized potential applications at the nanoscale. In 
nature, there are many examples demonstrating nanoscale organization having 
specific proteins and peptides that serve various chemical, mechanical and structural 
functions. Thus, there is great interest in engineering peptide and protein based 
systems for potential applications in nanosystems and devices [1-12].  
Peptides and proteins can be versatile building blocks for fabricating materials. In 
nature, there are many examples where the proteins are utilized as scaffolders such as 
collagen, keratin and have been instrumental in producing silica and calcite 
materials. Proteins have been used commonly in engineering, mostly to increase 
biocompatibility of implants, surface coating and making molecular scaffolds for use 
in tissue engineering [13-17]. Inorganic binding peptides can be used alone or as a 
fusion partner in functional proteins. Therefore, the methods to produce them via 
recombinant DNA technology and to check their inorganic binding functionality 
once they are inserted into different protein domains are crucial. The integration of 
proteins with signal transducers, protein-based biosensors, has mostly been utilized 
in many technologies including medical diagnostics [9, 11, 18-21]. 
More recently, hybrid materials composed of noble-metal nanostructures 
functionalized with protein receptor molecules (e.g. antibodies and enzymes) are of 
interest for developing novel chemo- and bio-sensors [22-27]. Ideally, the receptor 
coupling on the inorganic surface should be highly specific, highly ordered, 
reversible, and friendly to receptor molecules. Therefore, the multiplexed linking of 
proteins to a solid support in protein-based arrays is searched for the high-throughput 
study of proteins. Unfortunately, those devices are restricted via the challenges of 
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interfacing proteins with the solid support like loss of activity on immobilization 
owing to unfolding and the complex chemistries for coupling. 
Currently, various approaches utilize covalently coupling such as thiolylation [28] 
and silanization [29] for direct conjugation to functionalized layers that is used as an 
intermediary between the protein and surface of substrate  
Although current inorganic surface coupling approaches are based on creation of 
various self-assembled monolayer (SAM) linkages on metal inorganic surfaces, 
commonly using thiol or silane chemistry [4, 28-30]  the SAM-surface interactions 
are nonspecific, e.g. thiols bind to any noble metal – gold, silver, or platinum – more 
or less equally likely [28]. An exciting alternative to chemical coupling may be the 
use of combinatorially selected inorganic-binding peptides that are genetically 
incorporated onto the protein and can direct it to solid support without the need for 
further chemistry on the surface or the protein. Besides, the combinatorially selected 
inorganic-binding peptides have the potential to control protein orientation in 
specific and provide reversibility. 
1.1 The Purpose of the Research  
Phage [31] and cell surface display [32, 33] have become the major in vivo 
techniques for the selection of material-specific peptides [8, 18, 19, 32, 34, 35], 
generally called genetically engineered peptides for inorganics, GEPI [1, 2]. 
Recently, peptide sequences specific for platinum, quartz, cuprous oxide and 
hydroxyapatite, as well as many other materials and minerals, have been identified 
[1,2, 5-10, 18-21, 34-36]. Those peptides have been also characterized in terms of 
binding kinetics, affinities, and molecular structure [7-9, 18, 20, 21, and 37]. 
GEPIs can be used alone or as a fusion partner in functional proteins. Therefore, the 
methods to produce them via recombinant DNA technology and to check their 
inorganic binding functionality once they are inserted into different protein domains, 
is crucial. We aim to develop a recombinant production method for GEPI as a fusion 
partner in maltose binding protein. Two main objectives of this study are genetic 
engineering and purification of bi-functional protein in order to demonstrate 
applicability of the proposed method. maltose binding protein was chosen in order to 
facilitate its folding and solubility. Purification of the bi-functional protein has been 
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then optimized and the mass of resulting protein has been confirmed so that the study 
of its structure and functional properties can be now approached. 
We selected two GEPIs to produce as fusion partners, namely gold binding peptide 
(AuBP1, MW: 1454.7, WAGAKRLVLRRE) and quartz binding peptide (QBP2, 
MW: 1549, LPDWWPPPQLYH). We also used two different peptide linkers as S 
(G)
 3 and (PG) 3 between MBP and GEPI in the expression to test the effect of linkers 
in bi-functional activities of the fusion constructs. For the expression of the proteins, 
pMAL expression and purification system was used. The vectors, pMALc2X, were 
constructed, and bi-functional proteins were expressed in Luria Bertani medium and 
purified by amylose affinity chromatography. Purification of the bi-functional 
protein has been then optimized and the mass of resulting protein has been confirmed 
by mass spectrometry. We believe these constructs will lead to new facile 
alternatives in the formation of protein-metal and protein-metal oxide biosensors and 
bioassays. Moreover, the genetically designed bi-functional proteins can be used to 
create different material architectures in biomedical fields and nano-electronics due 
to some unique peptide features: (1) inorganic-binding peptides are robust and can be 
genetically-engineered or chemically-modified for tailored functionalities, (2) bind 
selectively to the inorganic targets at ambient conditions providing biology-friendly 
environment desirable for most bionanotechnology applications, (3) the various 
specific inorganic-binding peptide linkages can modify simultaneously two or more 
inorganic entities with different functional molecules or nanostructures. Overall, 
those new biomaterials have implications in a wide range of potential practical 
applications including the controlled bottom-up assembly of hybrid nanostructures in 
bionanophotonic and biosensing devices. 
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We summarize inorganic binding peptides and their potential use in nano and 
emerging technologies in the following sections. We also provide information on 
different fusion proteins and tagging systems and finally discuss maltose binding 
protein. 
2.1 Inorganic Binding Peptides  
In nature, proteins are reported to initiate, catalyze and mediate the fabrication of 
inorganic nano- and microstructures, which assemble into complex architectures. 
Therefore, a new emerging research field has been started in nanomaterials design 
termed molecular biomimetics and nanotechnology [1, 2]. The organisms using the 
organic-inorganic hybrid systems have evolved to use a part of their proteins in order 
to produce and bind the inorganic materials in vivo. These organisms synthesize 
inorganic binding proteins that bind and organize inorganic materials to highly 
ordered structures to perform excellent functions such as forming protective layers, 
supportive tissues, transferring ions and developing some optical and mechanical 
properties in favor of the organism. The inorganic material commonly include 
magnetite (Fe3O4) particles in magnetotactic bacteria or teeth of chiton [14]; silica 
(SiO2) as skeletons of radiolarian [13] or tiny light-gathering lenses and optical wave 
guides in sponges [15]; hydroxyapatite (Ca2C(OH)3) in bones [16] and dental tissues 
of mammals [17] calcium carbonate (CaCO3) in the shells of mollusks [3].  
In Figure 2.1, we demonstrate aragonite platelets separated by organic layer from 
abalone shell, magnetide particles produced in magnetotactic bacterium highly 
organized structures of hydroxyapatite crystallites in mouse enamel and layered 
silica structures in sponge spicule. a) Scanning electron microscope (SEM) image of 
a growth edge of abalone (Haliotis rufescens) displaying aragonite platelets (blue) 
separated by organic film (orange) that eventually becomes nacre (mother-of-pearl). 
This is a layered, tough, and high strength biocomposite (inset: transmission electron 
2. THEORITICAL BACKGROUND
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microscope (TEM). b) Magnetite nanoparticles formed by magnetotactic bacterium 
(Aquaspirillum magnetotacticum, inset TEM image) are single crystalline, single-
domained, and crystallographically aligned. c) Mouse enamel (SEM image) is hard, 
wear resistant material with highly ordered micro/nano architecture consisting of 
hydroxyapatite crystallites that assemble into woven rod structure (inset: schematic 
cross-section of a human tooth) d) Sponge spicule (with a cross-shaped apex shown 
in inset) of Rosella has layered silica with excellent optical and mechanical 
properties, a biological optical fiber (SEM image) [1]. 
 
Figure 2.1: Examples of biologically synthesized complex materials 
Because of the limited occurrence of naturally inorganic associated proteins, which 
could regenerate only inorganic material that they are associated with, some recent 
efforts have begun to instead identify small polypeptides that bind with high affinity 
to bulk materials using combinatorial biology approaches. The adapted phage display 
[31] and cell surface display [32, 33] technologies has emerged as a powerful 
strategy to select the inorganic-binding peptides. Nowadays, peptide sequences 
specific to metals [5, 18], metal oxides [8] and semiconductors [19, 35] and their 
potential use in material assembly and synthesis have been demonstrated. In addition 
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to the control of inorganic synthesis, self-assembly and recognition toward inorganic 
surfaces, combinatorial inorganic-binding peptides are robust and can be genetically-
engineered or chemically-modified for tailored functionalities including binding, 
erecting and linking [1, 2]. Besides that, designed inorganic-binding peptides can 
control the hierarchical assembly of inorganic building blocks to form hybrid 
nanostructures with capable of being tuned properties for nanobiotechnology 
applications [9-12, 21, 37, ]. 
2.1.1 Selection of Inorganic Binding Peptides 
Phage [31] and cell surface display [32, 33] have become the major in vivo 
techniques for the selection of material-specific peptides [8, 18, 19, 32, 34, 35], 
generally called genetically engineered peptides for inorganics, GEPI [1]. Recently, 
peptide sequences specific for platinum, quartz, cuprous oxide and hydroxyapatite, as 
well as many other materials and minerals, have been identified and characterized 
with regards to binding kinetics, affinities, and molecular structure [7, 8, 20, 35].  
Despite these most recent studies, there is still a need for detailed and quantitative 
data to address the molecular mechanisms that facilitate material-selective peptide 
binding on solid surfaces. The contribution of peptide primary and secondary 
structures most likely impact the recognition and binding to solid materials, and this 
information is essential for future peptide engineering, design, robust utility of these 
novel small biomolecules, either alone or as part of a larger protein unit, e.g., an 
enzyme [11, 38]. 
Recently, a FliTrx bacterial expression system [36] was used to select peptide 
sequences directed against cuprous and zinc oxide substrates [21] and as a scaffold 
for various metal nanoparticle self-assemblies [39] and formations. [40]. The FliTrx 
bacterial system uses the engineered extracellular flagellar protein (flagellin) to 
interact with external substrates. The main feature of FliTrx peptide libraries is that 
random peptides are inserted as fusions within the thioredoxin active-site loop [41], 
which is itself inserted into dispensable region of the flagellin gene, as opposed to the 
N-terminal location of fusions made to coat proteins in phage display techniques. 
Thus random peptides are displayed on the surface of bacteria within the structural 
context of the thioredoxin active-site loop, having both their N- and C- termini 
anchored by the rigid and stable tertiary structure of thioredoxin itself. in Figure 2.2 
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The novel gold-binding peptides (AuBPs)
surface library [36]. After five rounds of biopanning selection to enrich the 
population for affinitive inorganic binders, several numbers of clones were selected 
and sequenced to determine amino 
binding affinities of these 50 clones were analyzed using fluor
technique [7, 37] (shown in Figure
us to sort selected clones into three group
depending on their gold-binding affinity [37
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adhered cells from strong binding group, weak binding group and control plasmid 
free GI826 cells are listed in (Figure 2.4). 
 
Figure 2.4 : Binding affinity and selectivity of selected novel gold-binding clones by 
fluorescence microscopy 
As shown in Figure 1.4 examples of gold-adhered cells from strong binder group 
expressing strong gold-binding FliTrx protein (AuBP1, AuBP2) and from weak 
binder group expressing weak gold-binding FliTrx protein (AuBP30), in control 
experiment: plasmid free GI826 control cells used instead (A); examples of cross-
specificity of strong gold-binding clone (AuBP2) on silver and silicon dioxide 
surface with respective plasmid free GI826 control cells (B); schematic of selected 
FliTrx gold-binding cell attachment to gold surface (C); examples of gold affinity 
and specificity of strong gold-binding clone (AuBP2) on gold-pattern silicon wafer 
with respective plasmid free GI826 control cells (D).  
2.1.2 Proof of Demonstration Studies by Inorganic Binding Peptides 
The utility of polypeptides in practical engineering is becoming common in recent 
years by the speeding up development of protocols and procedures using molecular 
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biology that allow selection, designing, and tailoring of these versatile biomolecules 
as molecular building blocks. Proteins control fabrication and assembly of inorganic 
structures in the form of hard tissues with myriad different functionalities, such as 
mechanical, magnetic, and optical [1, 2, 5, 19, 34. Proteins have been used in 
engineering, mostly to increase biocompatibility of implants and surface coating. 
Recently, they are also used as engineering. More recently, hybrid materials 
composed of noble-metal nanostructures functionalized with protein receptor 
molecules (e.g. antibodies and enzymes) are of interest for developing novel chemo- 
and bio-sensors. [37, 38]. Ideally, the receptor coupling on the inorganic surface 
should be highly specific, highly ordered, reversible, and friendly to receptor 
molecules.  
Current inorganic surface coupling approaches are based on creation of various self-
assembled monolayer (SAM) linkages on metal inorganic surfaces, commonly using 
thiol or silane chemistry [4, 28-30].  However, the SAM-surface interactions are 
nonspecific, e.g. thiols bind to any noble metal – gold, silver, or platinum – more or 
less equally likely [28-30].  An exciting alternative to chemical coupling may be the 
use of combinatorially-selected inorganic-binding peptides as molecular linkers and 
assemblers [1, 2, 7, and 11]. In principal, in addition to the specific recognition of 
inorganic surfaces, combinatorially-selected inorganic-binding peptides are robust 
and can be genetically engineered or modified to tailor their functionalities such as 
synthesizing, binding, erecting and linking of inorganic nanostructures. [1, 2,  10, 11] 
Peptides, synthesized using cell surface display and phage display, specific to 
inorganic substrates, can be used to pattern inorganic substrates with structures at the 
micro scale [1, 2, 5, and 37]. This functionality can be practically used in the medical 
field for biosensing and even serving as a scaffold for immobilized protein activity 
and cell growth. Proof of polydimethylsiloxane (PDMS) stamps are used in soft 
lithography in order to pattern inorganic surfaces with molecules, such as thiols [10, 
11, 30, 28]. With the use of a PDMS stamp, one can apply the developed genetically 
engineered peptide specific to inorganic material (or GEPI) using as ink to the 
inorganic surface using physical force yielding high resolution patterning [11]. This 
has been shown with GEPI’s on gold surfaces, but it is yet to be tested on quartz 
surfaces [1, 2, and 11]. GEPI has used for patterning should also have a means of 
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optical visualization; the preferred method in this manuscript is to use UV 
fluorescent quantum dots (QDs). The pattern of the PDMS stamp may also vary [11].  
Genetically engineered peptides can be used as inks by PDMS stamping in creating 
functional bio-scaffolds. This can be applied to quartz surfaces, which are typically 
treated with silane chemistry for easy covalent bonding [10, 11, 30, and 28]. Current 
state of the art techniques using genetically engineered peptides are specifying 
peptide affinity to specific surfaces in order to use them as biosensors [1, 2, 5, 10, 
and 37]. 
2.2 Overview of Tag Protein Fusions 
The use of recombinant proteins has gradually increased in recent years due to an 
increase demand towards more biobased approaches desired in many technologies. 
Recombinant proteins containing a fusion partner, called affinity tag, are widely 
used. Recently, several epitope peptides, different proteins and domains have been 
developed to over-produce recombinant proteins to facilitate the purification and 
detection of the target proteins is well-characterized. The advantages of these 
affinity-tag systems: (a) one-step adsorption purification; (b) a minimal effect on 
tertiary structure and biological activity; (c) easy and specific removal to produce the 
native protein; (d) simple and accurate assay of the recombinant protein during 
purification; (e) applicability to a number of different proteins. However, each 
affinity tag is purified under its specific buffer conditions, which could affect the 
functionality of the protein of interest [12, 43, and 44]. Therefore, it is difficult to 
choose the right purification system for a specific protein of interest. The most 
frequently used and interesting systems are  His-tag, maltose-binding protein, 
glutathione S-transferase, FLAG-tag, calmodulin binding peptide and cellulose-
binding domain. The tag systems and their conditions are summarized in Table 2-1. 
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Affinity Tag Matrix Elution Condition 
Maltose Binding Protein Cross-linked amylose 10 mM maltose 
Glutathione S-transferase Glutathione 5-10 mM reduced glutathione 
Poly-His Ni-2+NTA, 
Co2+-CMA (Talon) 
Imidazole 20-250 mM or low pH 
HAT (natural histidine 
affinity tag 
Co2+-CMA (Talon) 150 mM imidazole or low pH 
Poly-Arg Cation exchange resin NaCl linear gradient from 0 to  
400 mM at alkaline pH > 8.0 
FLAG Anti-FLAG monoclonal 
antibody 
pH 3.0 or 2-5mM EDTA 
Strep-tag II Strep-Tactin (modified 
strepavidin) 
2.5 mM desthiobiotin 
S S-fragment of RNaseA 3 M guanidine thiocyanate,0.2 M citrate pH 
2.0, 3 M magnesium chloride 
c-myc Monoclonal antibody Low pH 
Calmodulin-binding 
protein 
Calmodulin EGTA or EGTA with 1 M NaCl 
Cellulose –binding 
protein 
Cellulose Family I: guanidine HCl or urea > 4 M  
Family II/III: ethylene glycol 
SBP Strepavidin 2 mM Biotin 
Chitin-binding domain Chitin Fused with intein: 30-50 mM dithiothreitol 
Generally, it is hard to decide which fusion system is best for a specific protein of 
interest. The target protein features such as stability and hydrophobicity and 
application of the purified protein help us to choose suitable expression system. In 
Table 2.1, there are the most common tag-protein fusion systems. 
Several different strategies have been developed to produce recombinant proteins on 
a large scale. One approach is to use a very small peptide tag that should not interfere 
with the fused protein. The most commonly used small peptide tags are poly-Arg-, 
FLAG-, poly-His-, c-myc-, S-, and Strep II-tag (Table 2.1). For some applications, 
small tags may not need to be removed. The tags are not as immunogenic as large 
tags and can often be used directly as an antigen in antibody production. The effect 
on tertiary structure and biological activity of fusion proteins with small tags depends 
on the location and on the amino acids composition of the tag [12, 26, and 49]. 
Table 2.1: There are the most used affinity tags, their matrices and elution conditions
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Another approach is to use large peptides or proteins as the fusion partner (Table 
2.2). The use of a large partner can increase the solubility of the target protein. The 
disadvantage is that the tag must be removed for several applications e.g. 
crystallization or antibody production.  
Tag Residues Sequence Size (kDa) 
Maltose-binding 
protein 
396 Protein 40.00 
Glutathione S-
transferase 
211 Protein 26.00 
Poly-His 2-10 (usually 6) HHHHHH 0.84 
HAT (natural 
histidine affinity tag 
19 KDHLIHNVHKEFHAHAHNK 2.31 
Poly-Arg 5-6 
(usually 5) 
RRRRR 0.80 
FLAG 8 DYKDDDDK 1.01 
Strep-tag II 8 WSHPQFEK 1.06 
S 15 KETAAAKFERQHMDS 1.75 
c-myc 11 EQKLISEEDL 1.20 
Calmodulin-binding 
protein 
26 KRRWKKNFLAVSAANRFKKISSSGAL 2.96 
Cellulose –binding 
protein 
27-189 Domains 3.00-20.00 
SBP 38 MDEKTTGWRGGHVVEGLAGELEQLRAR
LEHHPQGQREP 
4.03 
Chitin-binding 
domain 
51 TNPGVSAWQVNTAYTAGQLVTYNGKTY
KCLQPHTSLAGWEPSNVPALWQLQ 
5.59 
A various number of expression systems designed for numerous applications and 
compatibilities are available. Approximately 80% of the proteins used to solve three-
dimensional structures submitted to the protein data bank (PDB) in 2003 were 
prepared in an E. coli expression system. The T7 based pET expression system 
(commercialized by Novagen) is by far the most used in recombinant protein 
preparation (pET represents more than 90% of the 2003 PDB protein preparation 
systems). Systems using the λPL promoter/cI repressor (e.g., Invitrogen pLEX), Trc 
promoter (e.g., Amersham Biosciences pTrc), Tac promoter (e.g., Amersham 
Table 2.2: Residues, sequence and size of the most used affinity tags 
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Biosciences pGEX) and hybrid lac/T5 (e.g., Qiagen pQE) promoters are common. A 
radically different system is based on the araBAD promoter (e.g., Invitrogen pBAD). 
One of the most popular tag proteins used in the fusion protein system is maltose-
binding protein [27, 44, 45, 49, and 50]. MBP gained its popularity because it can 
achieve a high level of expression (up to 20–40% of total cellular proteins in 
Escherichia coli [46] and because it can increase the solubility of fusion proteins [42, 
45]. 
2.2.1. Maltose Binding Protein Expression Systems 
The 40 kDa maltose-binding protein (MBP) is encoded by the malE gene of E. coli 
K12 [46]. Vectors that facilitate the expression and purification of foreign peptides in 
E. coli by fusion to MBP were first described in 1988 [43]. Fused proteins can be 
purified by one-step affinity chromatography on cross-linked amylose. Bound fusion 
proteins can be eluted with 10 mM maltose in physiological buffer. Binding affinity 
is in the micro-molar range. Some fusion proteins do not bind efficiently in the 
presence of 0.2% Triton X- 100 or 0.25% Tween 20, while other fusions are 
unaffected. Buffer conditions are compatible from pH 7.0–8.5, and up to 1 M salt. 
Denaturing agents cannot be used. MBP can increase the solubility of overexpressed 
fusion proteins in bacteria, especially eukaryotic proteins [42, 49]. A spacer sequence 
coding for ten asparagines residues between the MBP and the protein of interest 
increases the chances that a particular fusion will bind tightly to the amylose resin. 
The MBP-tag can be easily detected using an immunoassay. It is necessary to cleave 
the tag with a site-specific protease. The MBP can be fused at the N- or C-terminus 
of the protein if the proteins are expressed in bacteria [46, 49]. N-terminal location 
can reduce the efficiency of translation. The MBP system is widely used in 
combination with a small affinity tag [49]. 
The maltose-binding protein (MBP) is one of the effective solubilizing agents when 
used as a fusion partner. In some cases, the fusion to MBP can promote proper 
folding of the attached protein into its biologically active conformation. Thus, MBP 
is likely to be capable of functioning as a general molecular chaperone in the context 
of a fusion protein [27, 42- 46, 49, 50] 
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2.2.2 Maltose Binding Protein Structure and Applications 
The bacterial periplasmic-binding protein (PBP) superfamily members, in particular 
the maltose-binding protein, have been used extensively to prototype a variety of 
biosensing platforms. This protein superfamily has the same basic two domain 
structure, and upon binding a recognized ligand, almost all PBPs undergo a 
conformational change to a closed structure [43, 46]. Many direct detection or 
reagentless sensing modalities have been utilized with maltose-binding protein for 
both in vitro and in vivo detection of target compounds. Signal transduction 
modalities developed to date include direct fluorescence, electrochemical detection, 
fluorescence resonance energy transfer (FRET)- based detection, surface-tethered 
FRET sensing, hybrid quantum dot FRET sensing, and enzymatic detection, each of 
which have different benefits, potential applications and limitations [12, 26, 27]. 
A common functional conformational change is also found in PBP family, which 
involves switching from the ‘open’ ligand-free form to a ‘closed’ or ligand-bound 
form. This transition is accomplished through a bending and swiveling twist motion 
about the hinge region, which is analogous to a ‘venus-fly-trap’ closing, see Figure 
2.5 (a, b) [26, 27]. A variety of analytical or signal transduction mechanisms have 
been used to monitor PBP binding and conformational changes, including direct and 
environmentally sensitive fluorescence, electrochemical and fluorescence resonance 
energy transfer (FRET), see Figure 2.5. 
The interest in exploiting PBPs for biosensing arises both from their specific 
recognition of myriad analytes approaching nanomolar concentrations in some cases 
and from the ligand-induced conformational changes that they undergo [12, 50]. It is 
believed that the common functional mechanism and wide specificity of PBPs 
originated during evolution by positive selective pressure on their hosts as they 
mediated solute recognition and uptake in the periplasm and directed chemotaxis [46, 
49]. Owing to the extensive understanding of its structure and function, maltose-
binding protein (MBP) is the prototypical member of this superfamily. MBP 
specificity is well known, the crystal structure in both the open and ligand-bound 
form has been solved [12, 26, 27, 42, 44-46, 50], and a variety of mutants that have 
different maltose sensitivities (Kds that range from nM to mM) have been created 
[27]. Moreover, MBP has been extensively utilized for recombinant protein 
purification over amylose resin [12, 26]. 
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MBP, are an excellent platform not only for biosensing but also for prototyping a 
variety of diverse sensing modalities for eventual use in various environmental, 
clinical and security applications [26, 27, 42, 44-46, 50]. 
 
Figure 2.5 : MBP structure and function 
In Figure 2.5 (a) A prototypic PBP structure is depicted; this has two lobes (green) 
that create the ligand-binding pocket and are joined by the hinge-binding region 
(pink). Upon binding the ligand, the PBP undergoes transition to the closed structure. 
PBPs present two intrinsic properties available for biosensor exploitation, either 
separately or when functioning in concert: recognition specificity and conformational 
change. Recognition specificity has been utilized for fluorescence- and FRET-based 
sensing. Conformational changes have been utilized for FRET-, electrochemical-, 
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fluorescent- and enzymatic-based sensing. (b) Ribbon and string rendering of MBP 
structure in the open form (right) and ligandbound closed form (left). MBP 
dimensions are ~30x40x65 A°. The two domains (lobes) are highlighted in green and 
grey. Upon binding maltose (purple), the lobes rotate ~35 A° and twist laterally ~8 
A° relative to each other [47]. Overall the amino- and carboxy-termini move ~7 A° 
closer to each other after binding Note the change in conformation of the overall 
structure upon binding maltose [46, 47]. 
Proteins interact with other macromolecules and inorganics to control the structures 
and functions of all biological tissues in organisms [1,2]. Biological hard tissues such 
as bones, dentin, enamel, and spines contain proteins together with inorganic 
minerals [13-17]. Design and engineering of proteins with desired properties such as 
specific binding affinity to selected inorganics, would open avenues to the 
engineering of materials with novel properties and broaden the knowledge about 
protein physics. Thus, binding of polypeptides to metal surfaces is of great interest in 
the field of nanotechnology, biomaterials and biomimetics. In biomaterials, protein 
adsorption is critical for the integration of an implant with tissue [4]. In the 
nanotechnology aspect, protein–surface interactions constitute the basis for 
functional biological/electronic constructs such as sensors, activators, etc. [1, 2, and 
30]. Biomimetics, i.e., gaining inspiration and guidance from nature have also gained 
considerable attention in recent years for the design concepts that introduce into 
technologies with novel properties [2]. In view of this approach, combinatorial and 
evolutionary techniques have been adopted for the creation and isolation of peptide 
sequences that bind specifically to solid surfaces, similar to the natural proteins that 
regulate crystal growth [2, 6, 19, 31-33, 47, 48]. 
2.3 Bioengineering New Bi-functional Proteins  
Recent advantages in protein engineering have come from creating multifunctional 
proteins, nowadays more attention is being paid to protein than to the gene itself [ 44, 
49, and 51]. High-throughput expression and purification strategies, such as affinity 
fusion tags, are necessary when conducting functional and structural studies of 
proteins. Using fusion proteins for protein purification is a routine practice in 
laboratories working on recombinant proteins. One of the most popular carrier 
proteins used in the fusion protein system is maltose-binding protein (MBP) [12, 43, 
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46, and 49]. MBP is one popular affinity tag because it can achieve a high level of 
expression (up to 20–40% of total cellular proteins in Escherichia coli [43, 46] and it 
can increase the solubility of fusion proteins.  The MBP is a member of the family of 
the periplasmic binding proteins involved in active transport and chemotaxis [26, 49, 
42, 46]. The protein expression is quietly high, especially; the expression level is 
higher in the cytoplasm than periplasm. It is shown that fusion with MBP can 
increase solubility of proteins expressed in E.coli [26, 49]. In addition to this, the 
system which maltose binding protein (MBP) is utilized for recombinant protein 
expression and purification provides the basis of general system for engineering 
families of reagentless biosensors [26].  
The important challenge presented by the process of protein microarray fabrication is 
the requirement for high-throughput expression and purification of proteins, since 
thousands of purified proteins are required for the generation of high-density protein 
microarrays. Fortunately, the advent of recombinant DNA technology and 
Polymerase Chain Reaction has simplified protein expression, allowing not only the 
study of existing proteins but also the production of new proteins with enhanced 
features. Consequently, over the past decade several technologies have been 
developed where the target proteins are manipulated at the genetic level to increase 
productivity. The use of genetically-fused affinity tags has been particularly 
successful, and this technique has become ubiquitous in research [26, 49, 43, and 
46].  
2.3.1 Application Area of Bi-functional Protein 
Nanostructures based on polypeptides have emerged as key hybrid systems for future 
nanobiotechnological applications so here peptides that have specific inorganic-
binding are utilized as the most favorable building blocks for the design and 
synthesis of nanostructures. These simple building blocks that can be modified and 
decorated with functional elements, and they can be employed in different 
applications. The useful applications of these structures as novel components of 
highly sensitive biosensors and diagnosis tools, drug delivery vehicles, and scaffolds 
for tissue engineering and regeneration, were already known [10, 11, 47, and 48]. 
The premise in a molecular biomimetic approach to nanotechnology is that, 
genetically engineered polypeptides for inorganics (GEPIs) could be used as linkers 
and building blocks for self-assembly of materials with controlled organization and 
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specific functions. The isolation methods and potential applications of genetically 
engineered peptides for inorganics (GEPIs) have been studying extensively in the 
recent years.  Specific peptides can now be used for the nucleation and growth of 
inorganic nanomaterials and structure [10, 11, 34, 37, 48]. Peptides specific for 
inorganic binding can be combined (i.e., genetically fused) with  proteins (i.e. 
enzymes) and other functional peptides that bind another moiety [38]. This approach 
can open up endless possibilities begin to emerge. Proteins have been used in 
engineering, mostly to increase biocompatibility of implants and surface coating, 
with their recent use in molecular scaffolds in tissue engineering, they can be 
extended towards new biobased approaches, utilized for novel technologies. 
 In relatively recent times, hybrid materials composed of noble-metal nanostructures 
functionalized with protein receptor molecules (e.g. antibodies and enzymes) are of 
interest for developing novel chemo- and bio-sensors [10, 11, 28-30, 48]. To 
assemble the recognition layer in these biosensor applications, different approaches 
have been used. The first approach is to immobilize the proteins by means of 
physisorption without adding any tags or chemical groups. In this approach, the main 
drawback is the un-oriented fashion of immobilization of the protein. These causes a 
loss in the activity of the protein adsorbed on the surface, because non-controlled and 
unoriented  adorption may triggers the adorption of the active site of the proteins. 
Another approach is creating an active chemical layer on the surface of interest using 
thiol or silane based linkages [10, 11, 28-30]. Following surface preparation proteins 
were immobilized on these chemically active surfaces through the amine or carboxyl 
groups. However, the immobilization of protein on target surface is carried out in a 
random way.  Therefore, the use inorganic binding peptides can be a unique utility 
on assembling biomolecules on any desired inorganic surface for many different 
applications including sensors and medical devices. 
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3.1 Materials 
3.1.1 Bacterial Strains 
3.1.1.1 Escherichia coli K12 TB1 
Escherichia coli strain K12 TB1 [F- ara ∆(lac-proAB) [Φ80dlac ∆(lacZ)M15] 
rpsL(StrR) thi hsdR] was purchased from New England Biolabs (Catalog # E4122S) 
and used for construction of expression vector. 
3.1.1.2 Escherichia coli K12 ER2507  
Escherichia coli strain K12 ER2507 [F- ara-14 leuB6 fhuA2 ∆(argF-lac)U169 lacY1 
glnV44 galK2 rpsL20 xyl-5 mtl-5 ∆(malB) zjc::Tn5(KanR) ∆(mcrC-mrr)HB101] was 
purchased from New England Biolabs (Catalog # E4121S) and used for construction 
of expression vector. 
3.1.1.3 Escherichia coli Max Efficiency
®
  DH5α™ 
Escherichia coli strain MAX Efficiency
® 
DH5α™ Competent Cells [F- 
φ80lacZ∆M15 ∆(lacZYA-argF) U169 recA1 endA1 hsdR17 (rk-, mk+) phoA 
supE44 λ- thi-1 gyrA96 relA1] was purchased from Invitrogen (Catalog # K4520-01 
20) and used for general cloning and blue/white screening without IPTG. Strain is 
resistant to T1 bacteriophage construction of cloning vector.  
3.1.2 Expression Vectors 
3.1.2.1 pMAL™-2 Vectors 
The pMAL™-2 vectors (given in Appendix A) provide a method for expressing and 
purifying a protein produced from a cloned gene. The cloned gene is inserted down-
stream from the malE gene of E. coli, which encodes maltose-binding protein 
(MBP), resulting in the expression of an MBP fusion protein (1,2). The method uses 
the strong “tac” promoter and the malE translation initiation signals to give high-
level expression of the cloned sequences (3,4), and a one-step purification of the 
3. EXPERIMENTAL PART 
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fusion protein using MBP’s affinity for maltose (5). The vectors express the malE 
gene (with or without its signal sequence) fused to the lacZα gene. Restriction sites 
between malE and lacZα are available for inserting the coding sequence of interest. 
Insertion inactivates the β-galactosidase α-fragment activity of the malE-lacZα 
fusion, which results in a blue to white color change on Xgal plates when the 
construction is transformed into an α-complementing host such as TB1 or JM107 
[52]. The vectors carry the lacIq gene, which codes for the Lac repressor. This keeps 
expression from Ptac low in the absence of IPTG induction. The pMAL-2 vectors 
also contain the sequence coding for the recognition site of a specific protease, 
located just 5´ to the polylinker insertion sites. This allows MBP to be cleaved from 
the protein of interest after purification. The pMALc2X vector has a site for Factor 
Xa. Factor Xa cleaves after its four amino acid recognition sequence, so that few or 
no vector-derived residues are attached to the protein of interest, depending on the 
site used for cloning.  
3.1.3 Enzymes 
All the enzymes are recombinant and produced in E. coli. The restriction enzymes 
were purchased from New England Biolabs, the buffers used accordingly as provided 
and suggested by the supplier. All the restriction enzymes were supplied with the 
reaction buffer called 10X NEBuffer with each restriction endonuclease to ensure 
optimal (100%) activity. Most of the enzymes were supplied with one of four 
standard NEBuffers. Occasionally, an enzyme has specific buffer requirements not 
met by one of the four standards. Some restriction enzymes require BSA at a final 
concentration of 100 µg/ml for optimal activity.  
3.1.3.1 Lysozyme (EC 3.2.1.17) from Chicken Egg white 
50,000 units/mg lyophilized powder containing sodium acetate buffer salts and 
sodium chloride was purchased from Sigma (Catalog # L7001). It was dissolved in 
deionized water to get 10-20 mg/ml concentration. This enzyme breaks down the cell 
walls of bacteria so it was used for cell lysis. 
3.1.3.2 MscI Restriction Endonuclease  
The source of the restriction enzyme is an E. coli strain that carries the MscI gene 
from Micrococcus species. It was supplied with NEBuffer 4 (10X) from New 
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England Biolabs (Catalog # R0534S). Its recognition and cutting site is as follows, 
5’-TGG^CCA-3’. It was used for construction of expression vector. 
3.1.3.3 PstI Restriction Endonuclease  
The source of the restriction enzyme is an E. coli strain that carries the PstI gene 
from Providencia stuartii 164. It was supplied with NEBuffer 3 (10X) and BSA 
(100X) from New England Biolabs (Catalog # R0140T). Its recognition and cutting 
site is as follows, 5’-CTGCA^G-3’. It was used for construction expression vector. 
3.1.3.4 NlaIV Restriction Endonuclease  
 The source of the restriction enzyme is an E. coli strain that carries the NlaIV gene 
from Neisseria lactamica. It was supplied with NEBuffer 4 (10X) and BSA (100X) 
from New England Biolabs (Catalog # R0126S). Its recognition and cutting site is as 
follows, 5’-GGN^NCC-3’. It was used for construction expression vector. 
3.1.3.5 XmnI Restriction Endonuclease  
The source of the restriction enzyme is an E.coli strain that carries the XmnI gene 
from Xanthomonas manihotis 7AS1. It was supplied with NEBuffer 4 (10X) and 
BSA (100X) from New England Biolabs (Catalog # R0194S). Its recognition and 
cutting site is as follows, 5’-GAANN^NNTTC-3’ It was used for digestion of 
expression vector.  
3.1.3.6 Taq DNA Polymerase  
It was 5 U/µl in its storage buffer with its discrete reaction buffer called 10X PCR 
Buffer (100 mM Tris-HCl (pH 8.3), 500 mM KCl, 1.5 mM MgCl2) and was 
purchased from New England Biolabs (Catalog # M0273X). 
3.1.3.7 Quick T4 Ligase 
It provides ligation of cohesive end or blunt end DNA fragments in 5 minutes at 
room temperature (25°C). It was supplied with Quick Ligation™ Kit New England 
Biolabs (Catalog # M2200S). It was used for cloning into vectors. 
3.1.3.8 Factor Xa Protease  
 Factor Xa cleaves after the arginine residue in its preferred cleavage site Ile-(Glu or 
Asp)-Gly-Arg. It will sometimes cleave at other basic residues, depending on the 
conformation of the protein substrate. The most common secondary site, among 
  
24
those that have been sequenced, is Gly-Arg. There seems to be a correlation between 
proteins that are unstable in E.coli and those that are cleaved by Factor Xa at 
secondary sites; this may indicate that these proteins are in a partially unfolded state 
[46]. Factor Xa will not cleave a site followed by proline or arginine. It was from 
England Biolabs (Catalog # P8010S). 
3.1 4 Protein Molecular Weight Markers  
 The Protein Molecular Weight Markers are Unstained Protein Molecular Weight 
Marker from Fermentas (Catalog # SM0431) and Protein Marker, Broad Range (2-
212 kDa) from New England Biolabs (Catalog #P7702S) (shown in Appendix B) 
3.1.5 DNA Molecular Weight Markers  
The used DNA markers are Lambda DNA/EcoRI+HindIII Marker 3, purchased from 
Fermentas (Catalog #SM0193) and Lambda DNA/Eco130I (StyI) Marker 16 from 
Fermentas (Catalog # SM0161) and PhiX174 DNA/BsuRI (HaeIII) Marker 9 from 
Fermentas (Catalog #SM0252) (see in Appendix C). 
3.1.6  Oligonucleotides and Primers   
The oligonucleotides and primers were purchased from Invitrogen as lyophilized 
form. 
(PG)3-AuBP1   5'- TAT ATA TTT TGG CCA GGC CCG GGC CCG  
   GGC TGG GCG GGC GCG AAA CGT CTG GTG  
   CTG CGT CGT GAA TAA TAA CTG CAG CGC  
   CCG CGC -3' 
SGGG-AuBP1 5'- TAT ATA TTT GGA TCC GGC GGC GGC TGG  
   GCG  GGC GCG AAA CGT CTG GTG CTG CGT  
   CGT GAA TAA TAA CTG CAG CGC CCG CGC -3' 
(PG)3-QBP2  5'- TAT ATA TTT TGG CCA GGC CCG GGC CCG  
   GGC CTG CCG GAT TGG TGG CCG CCG CCG  
   CAG CTG TAT CAT TAA TAA CTG CAG CGC  
   CCG CGC -3' 
SGGG-QBP2  5'- TAT ATA TTT GGA TCC GGC GGC GGC CTG  
   CCG GAT TGGTGG CCG CCG CCG CAG CTG TAT  
   CAT TAA TAA CTG CAG CGC CCG CGC -3' 
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Forward primer (SGGG-GEPI)     5’-TAT ATA TTT GGA TCC GGC  
     GGC GGC -3’ 
Reverse primer (SGGG-GEPI)      5’-GCG CGG GCG CTG CAG TTA  
     TTA TTC-3’ 
Forward primer ((PG)3-GEPI)       5’-TAT ATA TTT TGG CCA GGC  
     CCG GGC -3’ 
Reverse primer ((PG)3-GEPI)        5’-GCG CGG GCG CTG CAG TTA  
     TTA TTC-3’ 
Sequencing malE Forward Primer (24-mer) 
Sequence:   5´GGTCGTCAGACTGTCGATGAAGCC 3´ 
Sequencing Reverse Primer (21-mer) 
Sequence:   5´ GAAAGGGGGATGTGCTGCAAG 3´  
3.1.7 Bacterial Culture Media    
3.1.7.1 LB Medium 
20 g LB Broth including 10 g tryptone, 5 g NaCl and 5 g yeast extract (Sigma) was 
dissolved in distilled water up to 1L. in addition, the pH was adjusted to 7.0-7.5 with 
10 M NaOH and then sterilized for 15 minutes less than 1.5 Atm at 121οC.  
3.1.7.2 LB Agar Medium 
35 g LB Agar including 10 g tryptone, 5 g NaCl, 5 g yeast extract and 15 g agar 
(Sigma) was dissolved in distilled water up to 1 L. and the pH was adjusted to 7.0-
7.5 with 10 M NaOH and then sterilized for 15 minutes under 1.5 Atm at 121οC.  
3.1.7.3 LB Medium (containing 2% glucose) 
 LB Broth containing 10 g tryptone, 5 g NaCl , and 5 g yeast extract and 2 g glucose 
(Sigma) was dissolved in distilled water up to 1L. in addition, the pH was adjusted to 
7.0-7.5 with 10 M NaOH and then sterilized for 15 minutes less than 1.5 Atm at 
121οC.  
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3.1.7.4 SOC Medium  
SOC medium including 2% tryptone 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, 10 mM MgSO4 and 20 mM glucose was supplied with pCR®2.1-
TOPO® TA Cloning Kit (Catalog # K4500-01, Invitrogen)  
3.1.8 Stock Solutions    
3.1.8.1 1000x Ampicillin (Sodium Salt) 
1 g Ampicillin (Sigma) was dissolved in 10 ml deionized water, sterilized by 
filtration using 0.22µm filter. This is a 1000x stock solution and stored at -20οC. Its 
working strength is 100µg/ml.  
3.1.8.2 X-gal/IPTG Stock Solution  
1.25 g IPTG (Sigma) and 1 g X-gal (Fermentas) were dissolved in 25 ml DMF 
(Riedel-de-Haen). The solution was stored at -20οC in the dark.  
3.1.8.3  1 M IPTG Stock Solution  
2.38 g IPTG was dissolved in 10 ml deionized water, sterilized by filtration using 
0.22µm filter and stored at -20οC 
3.1.8.4 Glycerol Stock Solution  
80 ml glycerol (Riedel-de-Haen) and 20 ml distilled water were mixed to get 80% 
(w/v) solution. It was sterilized for 15 minutes under 1.5 atm at 121οC. 
3.1.9 Buffers 
3.1.9.1 Na-Ac Buffer  
3 M of Na-Ac (Riedel-de-Haen) was dissolved in 65 ml distilled water. pH was 
adjusted to 5.2 and distilled water was added up to 100 ml. 
3.1.9.2 10X TBE Buffer (1000ml) 
108 g of Tris base, 55 g boric acid and 20 ml 0.5 M EDTA at pH 8.0 were dissolved 
in 1 liter deionized water, its pH was titrated to 8.3 and sterilized for 15 minutes 
under 1.5 atm at 121οC. 
3.1.9.3 Column Buffer (1000ml) 
20 ml 1.0 M Tris-HCl, pH 7.4, and 2.0 ml 0.5 M EDTA were mixed and 11.7 g NaCl 
was dissolved this solution. Optionally, 1.0 ml 1M sodium azide and 0.7 ml 
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β−mercaptoethanol were added into this solution and final volume was adjusted to 1 
liter with distilled water. 
3.1.9.4 Elution Buffer (1000ml) 
4 g Maltose was dissolved in 1 liter column buffer without beta-mercaptoethanol 
3.1.10 Chemicals 
Amylose resin in 20% Ethanol was purchased from New England Biolabs (Catalog # 
E8021). 
Tris, NaOH, bromophenol blue, SDS, HCl, CBB-R250, CBB-G250, glacial acetic 
acid, glucose, MgCl2, TEMED, NaH2PO4 and EDTA were purchased from Merck., 
NaCl, NH4Cl, CaCl2, isopropanol, glycerol, absolute ethanol, absolute methanol and 
acetic acid (glacial) were purchased from Fluka.  
Maltose, beta-mercaptoethanol, NaN3, DTT, RbCl2, acrylamide, APS, N,N'-
Methylenebisacrylamide and electrophoresis grade glycine were purchased from 
Sigma. 
3.1.11 Computer Software 
Gel Documentation System: UVIPhotoMW Version 99.05 for Windows 95 & 98, 
UVItec Limited. 
Homology search: Basic Local Alignment Search Tool, BLAST. Standard protein 
BLAST (blastp) (Altschul et al. 1990; Nakamura et al., 2000). Available at 
http://www.ncbi.nlm.nih.gov/BLAST/ 
Nucleotide alignments: Multiple sequence alignment tools, ClustalW (Higgins et al., 
1994). Available at http://www.ebi.ac.uk/clustalw/index.html 
Translator tool: JustBio Translator tool, (Rodriguez P.). Available at 
www.justbio.com. 
3.2 Instruments 
Instruments are given in Appendix D. 
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3.3 Methods 
3.3.1 Construction of Bi-functional Protein Vector 
The desired vector construction was accomplished by firstly design of 
oligonucleotides and primers for PCR, secondly PCR amplification of 
oligonucleotides, then restriction endonuclease digestion of DNA fragments and 
vector, and lastly cloning the DNA fragments into expression vector.  
3.3.1.1 Oligonucleotides and Primer Design  
In order to construct the bi-functional protein vector the required oligonucleotides 
and primers were designed according to amino acid sequence of GEPI with linker 
and cloning strategy of expression vector and synthesized as lyophilized form by 
Invitrogen (Figure 4.2, Figure 4.3, Figure 4.4, and Figure 4.5). The polylinker site of 
vector has a number of regions, which are recognized by a specific endonuclease. 
Therefore, the base sequence of GEPI with linker should contain the appropriate 
recognition sites for restriction endonuclease to be used in cloning strategy.  
3.3.1.2 Amplification of Double Stranded DNA from Oligonucleotides by PCR 
 Designed oligonucleotides of SGGG-AuBP1, (PG)3-AuBP1, SGGG-QBP2 and 
(PG)3-QBP2 coding sequence (Figure 4.2, Figure 4.3, Figure 4.4, Figure 4.5) which 
have two restriction endonuclease recognition sites and two stop codons at the end of 
the specific peptide sequence were amplified. Forward and reverse primers, which 
are complementary to the DNA region targeted, were used for amplification. Taq 
DNA polymerase was used for the polymerase chain reaction. During optimization 
of PCR reaction, the following PCR reaction was set up for each template DNA and 
different annealing temperatures were tried to adjust the PCR reaction. After 
optimization, the proper PCR conditions were determined for each template (Table 
3.1-3.4)  
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Reagent Volume (µl) 
Sterile d H2O 39,3 
10X Taq Buffer
 
5,0 
10 mM dNTP (2.5mM each) 2,0 
25 mM MgCl2 3,0 
Forward Primer (10 pmole) 1,0 
Reverse  Primer (10 pmole) 1,0 
Template DNA (1 µg ) 0,5 
Taq DNA polymerase 0,2 
Total volume 50 
Temperature(○C) Time Cycles 
95 2 min 1 
94 30 sec 
 
30 
58 30 sec 
72 1 min 
72 20 min 1 
Temperature(○C) Time Cycles 
95 2 min 1 
94 30 sec 
 
30 
50 30 sec 
72 1 min 
72 20 min 1 
  
Table 3.1: Polymerase Chain Reaction (PCR)
Table 3.2: PCR conditions for SGGG-AuBP1 and (PG)3- AuBP1  
Table 3.3: PCR conditions for SGGG-QBP2 
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Temperature(○C) Time Cycles 
95 2 min 1 
94 30 sec 
 
30 
60 30 sec 
72 1 min 
72 20 min 1 
3.3.1.3  Agarose Gel Electrophoresis of PCR Products  
Agarose gel electrophoresis was carried out for separating and analyzing of DNA 
fragments. The agarose gel was 2,5% because the gel of 2,5 % shows good resolution 
for small fragments (0.05–1kb). Our fragments are 87 mer or 81 mer.  Lambda 
DNA/Eco130I (StyI) Marker 16 from Fermentas (Catalog # SM0161) in Appendix C 
was used as a marker.  
3.3.1.4 Purification of PCR Products via Gel Extraction Procedure   
PCR products were extracted from LMP agarose gel using MinElute Extraction Kit 
from Qiagen (Catalog # 28604) 
1. DNA fragment is excised from agarose gel with a clean scalpel. Gel slices are put 
into microfuge tubes and their weight is calculated. 
2. A 3-gel volume of QG buffer is added to 1 volume of gel slice. (600 µl for 100 
mg gel). When gels are excised from a %2 or more concentrated gel, a 6-gel 
volume of QG buffer is applied. 
3. Sample is incubated at 50οC for 10 min. by vortexing every 2 min. 
4. After the gel completely dissolved, the color of the mixture is checked. QG 
buffer contains a pH indicator and gives a yellow color at pH < 7.5, the optimum 
pH for DNA adsorption. If the color of the mixture is not yellow, 10 µl of 3 M 
sodium acetate, pH5.0 is added. 
5. After the gel is dissolved, 1 gel volume of room temperature isopropanol is added 
and mixed by inverting the tube several times. 
6. Sample is applied to min-elute column and centrifuged for 1 min. at 13000 rpm. 
Table 3.4: PCR conditions for (PG)3-QBP2
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7. Flow-through is discarded from collection tube. 
8. 500 µl QG buffer is applied to column and centrifuged for 1 min. at 13000 rpm. 
9. Flow-through is discarded from collection tube and centrifuged for additional 1 
min. 
10. Spin column placed in a 1, 5 ml. microfuge tube and 10 µl Elution Buffer is 
applied to elude the DNA. After 1 min. incubation tube is centrifuged for 1 min. 
11. Eluted DNA is stored at -20οC for further use.  
3.3.1.5 Quantization of Nucleic Acids 
Determination of the concentration for unknown DNA fragments in microplates was 
carried out by measuring absorbance at 260 nm using followed by correction for light 
pathlength. The subsequent pathlength corrected absorbance was then transformed 
using the appropriate conversion factor indicated in Table 3.5. 
Nucleic Acid Species Concentration for 1 A260 Unit (µg/ml) 
dsDNA 50 
 ssDNA (oligonucleotides) 33 
ssRNA 40 
3.3.1.6 Restriction Enzyme Digestions of DNA Encoding for Linker-GEPI 
Amplified four kinds of DNA fragments which are capable of coding for each GEPI 
with linker sequence, in turn, SGGG-AuBP1, (PG)3-AuBP1, SGGG-QBP2 and 
(PG)3-QBP2 were digested with the specific restriction endonucleases for cloning 
them produced by PCR into pMAL vector. In order to obtain 5’ - blunt end from 
each DNA different restriction enzymes were used, but the same restriction enzyme, 
PstI, was used to get 3’- sticky end from each DNA. The restriction enzyme 
digestion reactions are in Table 3.6, Table 3.7, Table 3.8, Table 3.9,. Reactions were 
incubated at 37οC for 3 h. and then at 80οC for 20 minutes for enzyme inactivation. 
Digestion reaction was run on a 2.5 % agarose gel. 
Table 3.5: Commonly accepted absorbance to concentration conversion for nucleic 
acids. Indicated values are accepted average values for absorbance 
measurements at 260 nm with a 1 cm pathlength 
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Reagent Volume (µl) 
DNA (631 ng/µl) 25 
10X NEBuffer 4
 
5,0 
NIaIV  (1 U/µl) 6,0 
PstI (20 U/µl) 0,5 
Sterile distilled 
water 
13,5 
Total volume 50 
Reagent Volume (µl) 
DNA (514 ng/µl) 25 
10X NEBuffer 1
 
5,0 
MscI  (3 U/µl) 2,0 
PstI (20 U/µl) 2,0 
Sterile distilled 
water 
16 
Total volume 50 
Reagent Volume (µl) 
DNA (410 ng/µl) 25 
10X NEBuffer 4 
 
5,0 
NIaIV  (1 U/µl) 6,0 
PstI (20 U/µl) 0,5 
Sterile distilled water 13,5 
Total volume          50 
Table 3.6: Digestion Reaction of SGGG-AuBP1 
Table 3.7: Digestion Reaction of (PG)3-AuBP1
Table 3.8: Digestion Reaction of SGGG-QBP2 
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Reagent Volume (µl) 
DNA (474 ng/µl) 25 
10X NEBuffer 1
 
5,0 
MscI  (3 U/µl) 2,0 
PstI (20 U/µl) 2,0 
Sterile distilled 
water 
16 
Total volume 50 
3.3.1.7 Agarose Gel Electrophoresis of PCR Products 
Agarose gel electrophoresis was applied for analyzing and separating of DNA 
fragments. The agarose gel was 2,5% because the gel of 2,5 % shows good resolution 
for small fragments (0.05–1kb). Our fragments are 54 mer and 48 mer.  Lambda 
DNA/Eco130I (StyI) Marker 16 from Fermentas (Catalog # SM0161) in Appendix C 
was used as a marker. 
1.8  Purification of PCR Products via Gel Extraction Procedure  
Following digestion reaction, PCR products were extracted from LMP agarose gel 
using MinElute Extraction Kit from Qiagen (Catalog # 28604). 
1. DNA fragment is excised from agarose gel with a clean scalpel. Gel slices are put 
into microfuge tubes and their weight is calculated. 
2. A 3-gel volume of QG buffer is added to 1 volume of gel slice. When gels are 
excised from a %2 or more concentrated gel, a 6-gel volume of QG buffer is 
applied. 
3. Sample is incubated at 50οC for 10 min. by vortexing every 2 min. 
4. After the gel completely dissolved, the color of the mixture is checked. QG 
buffer contains a pH indicator and gives a yellow color at pH < 7.5, the optimum 
pH for DNA adsorption. If the color of the mixture is not yellow, 10 µl of 3 M 
sodium acetate, pH5.0 is added. 
 Table 3.9: Digestion Reaction of (PG)3-QBP2
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5. After the gel is dissolved, 1 gel volume of room temperature isopropanol is added 
and mixed by inverting the tube several times. 
6. Sample is applied to min-elute column and centrifuged for 1 min. at 13000 rpm. 
7. Flow-through is discarded from collection tube. 
8. 500 µl QG buffer is applied to column and centrifuged for 1 min. at 13000 rpm. 
9. Flow-through is discarded from collection tube and centrifuged for additional 1 
min. 
10. Spin column placed in a 1, 5 ml. microfuge tube and 10 µl Elution Buffer is 
applied to elude the DNA. After 1 min. incubation tube is centrifuged for 1 min. 
11. Eluted DNA is stored at -20οC for further use.  
3.3.2 Competent Cell Preparation  
Competent cells have more easily altered cell walls that DNA can be passed through 
easily. These cells readily incorporate foreign DNA. If the cells are not already 
competent, it can be made more competent through calcium chloride and heat shock. 
This is especially easy with cells undergoing very rapid growth. Rubidium Chloride 
Method was used for E.coli K12 ER2507 and TB1 strains. This procedure works 
with most strains and should routinely give > 107 cfu/ug of pBR322 with reasonably 
healthy K-12 derivatives [52]. Frozen cells last at least a year. The following 
protocol was used to generate E. coli that is chemically competent for transformation 
of ligation reactions or plasmids. 
Chemically Competent Preparation Protocol: 
1. Single line of colony of E. coli strain is inoculated to 5 ml Luria Bertani (LB) 
liquid medium and incubated at 37oC and 250 rpm overnight. 
2. 0.5 ml of overnight culture is inoculated into 50 ml of LB liquid medium and 
incubated at 37o C, 250 rpm until optical density at 600 nm (OD600) reached 0.2-
0.3. 
3. The culture is centrifuged for 10 minutes at 4000x g, 4o C in Beckman Coulter 
J109 Avanti centrifuge with JA30.50i rotor. 
4. The supernatant is removed and the pellet dried on a tissue paper. 
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5. The pellet is gently resuspended in ice-cold 9 ml RF1 solution (100mM RbCl2, 
50 mM MnCl2, 30mM KAc (pH: 7.5), 10mM CaCl2, Glycerol 15 % (w/v); pH is 
adjusted to 5.8 with 0.2 M HCl, solution is sterilized with 0.22µm filter) and 
centrifuged for 10 minutes at 4000 x g, 4o C in Beckman Coulter Avanti J-30I 
centrifuge with JA-30.50i rotor. 
6. The supernatant is removed and the pellet is gently resuspended in ice cold 1 ml 
RF2 solution (10mM MOPS (0.5 M stock, pH: 6.9), 10mM RbCl2, 75 mM CaCl2, 
Glycerol 15 % (w/v); adjust pH to 6.8 with NaOH, sterilize with 0.22 µm filter) 
and kept on ice 1-2 hours. 
7. 50 µl of competent cell solution is sampled to pre-chilled microfuge tubes and 
stored at –80o C for transformation. 
All tubes, rotors, solutions should be kept on ice or at -80°C before use. When 
resuspending pellet cells, motorized pipette was used instead of a vortex to avoid 
lysis.  
3.3.3 Chemical Transformation of pMAL c2X into E.coli K12 TB1 
The commercial expression vector was transformed into competent cell E. coli K12 
TB1 to prepare glycerol stocks and express the wild type MBP. The used protocol 
was as follows:  
1. The vial of TB1 chemically competent cells in microfuge tube is thawed on ice.  
2. 0.1-0.5 µl of vector is added into the vial of competent cells, mixed gently and 
incubated on ice for 30 minutes. 
3. The cells are heat shocked at 42o C for exactly 60 seconds without shaking. 
4. The tubes are immediately transferred to ice and are incubated on ice for 10 
minutes. 
5. 0.2 ml of room temperature SOC medium and 0.8 ml LB medium are added to 
the mixture of vector and competent cells in the microfuge tube.  
6. The tubes are tightly capped and shacked horizontally at 200 rpm at 37o C for 15 
minutes. 
7. 4 dilutions (25, 50, 75 and 150 µl) are spread from the transformation reaction 
onto pre-warmed LB agar plates containing Ampicillin by using a spreader. 
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8. The plates are incubated at 37o C overnight. 
3.3.3.1 Glycerol Stock Preparation 
After overnight incubation of plates, the colonies were picked with a sterile toothpick 
and stabbed onto a master LB agar plate with Ampicillin of 100µg/ml. At the same 
time, the toothpick carrying one colony was put in 3 ml liquid LB containing 
100µg/ml of Ampicillin and incubated at 37o C overnight. In order to prepare 
glycerol stock for a long storage, 850 µl of this bacterial culture was mixed with 150 
µl 80 % glycerol and stored -80 o C at least one year. 
3.3.3.2 Plasmid DNA Isolation (Mini Prep) 
Following transformation, the colonies received the plasmid were chosen from LB 
agar containing 100 µg/ml Ampicillin plates and grown in 3 ml liquid LB containing 
100 µg/ml overnight. Plasmid DNA was isolated for further applications by using 
High Pure Plasmid Isolation Kit from Roche (Catalog # 1 754 785). Isolation 
procedure is described below: 
1. 3 ml of the culture is centrifuged 60 seconds at 6000 x g. 
2. The supernatant is discarded. 
3. The pellet is resuspended in 250 µl Suspension Buffer + RNase. 
4. 250 µl Lysis Buffer is added, mixed gently by inverting the tube 3 to 6 times and 
incubated at 15-25 C for 5 minutes. 
5. 350 µl chilled Binding Buffer is added mixed gently and incubated on ice for 5 
minutes. 
6. The samples are centrifuged at 13 000 x g for 10 minutes. 
7. High Pure Filter Tubes are interested into Collection Tubes. 
8. Supernatant is transferred to High Pure Filter Tube and centrifuged at 13 000 x g 
for 1 minute. 
9. The flow-through is discarded. 
10. 500 µl Wash Buffer l is added and centrifuged at 13 000 x g for 1 minute. 
11. The flow-through is discarded. 
12. 700 µl Wash Buffer II is added centrifuged at 13 000 x g for 1 minute. 
13. The flow-through is discarded and an additional 1 minute centrifuged at  
13 000 x g is performed. 
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14. The filter tube is placed in 1.5 ml microcentrifuge tube and 100 µl Elution 
Buffer is added. 
15. The isolated plasmid is checked by running on an agarose gel. 
3.3.3.3 Agarose Gel Electrophoresis of Purified pMALc2X Vector 
Agarose gel electrophoresis was applied for analyzing of pMALc2X.. The agarose 
gel was 0.7 % because the plasmid size is over 6kb.  Lambda DNA/EcoRI+HindIII 
Marker 3, purchased from Fermentas (Catalog #SM0193) in Appendix C was used as 
a marker 
3.3.3.4 Restriction Enzyme Digestion of pMALc2X Vector 
For cloning a fragment produced by PCR into a pMAL vector. The PCR fragment 
begins with a blunt end, and that a stop codon followed by a PstI site has been 
incorporated into the 3’ end. Therefore pMALc2X vector was digested with 20 units 
of XmnI and 30 Units of PstI. For complete digestion of the pMALc2X digest was 
checked by running 4 µl on an agarose gel. At the same time, PCR fragments 
digested were run to estimate their concentrations electrophoretically. The digestion 
reaction reagents for pMALc2X vector are shown in Table 3.10. 
Reagent Volume (µl) 
DNA (180 ng/µl) 25  
10X NEBuffer 1 
 
5,0 
XmnI  (20 U/µl) 1,0 
PstI (20 U/µl) 1,5 
Sterile distilled water 17,5 
Total volume 50 
3.3.3.5 Agarose Gel Electrophoresis of Digested pMALc2X Vector 
Agarose gel electrophoresis was carried out for analyzing f the vector is cut and 
separating from the gel. The agarose gel was 0.7 % because the plasmid size is over 
6kb.  Lambda DNA/EcoRI+HindIII Marker 3, purchased from Fermentas (Catalog 
#SM0193) in Appendix C was used as a marker 
Table 3.10: Digestion Reaction of pMALc2X vector 
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3.3.3.6 Purification of Digest pMALc2X via Gel Extraction Procedure 
Following digestion reaction, vector was extracted from LMP agarose gel using 
Qiaquick Gel Extraction Kit from Qiagen (Catalog # 28604). 
1. DNA fragment is extracted from agarose gel with a clean scalpel. Gel slices are 
put into microfuge tubes and their weight is calculated. 
2. A 3-gel volume of QG buffer is added to 1 volume of gel slice. (600 µl for 100 
mg gel). When gels are excised from a %2 or more concentrated gel, a 6-gel 
volume of QG buffer is applied. 
3. Sample is incubated at 50οC for 10 min. by vortexing every 2 min. 
4. After the gel completely dissolved, the color of the mixture is checked. QG 
buffer contains a pH indicator and gives a yellow color at pH<7.5, the optimum 
pH for DNA adsorption. If the color of the mixture is not yellow, 10 µl of 3 M 
sodium acetate, pH5.0 is added. 
5. After the gel is dissolved, 1 gel volume of room temperature isopropanol is added 
and mixed by inverting the tube several times. 
6. Sample is applied to min-elute column and centrifuged for 1 min. at 13000 rpm. 
7. Flow-through is discarded from collection tube. 
8. 500 µl QG buffer is applied to column and centrifuged for 1 min. at 13000 rpm. 
9. Flow-through is discarded from collection tube and centrifuged for additional 1 
min. 
10. Spin column placed in a 1,5 ml. microfuge tube and 10 µl Elution Buffer is 
applied to elude the DNA. After 1 min. incubation tube is centrifuged for 1 min. 
11. Eluted DNA is stored at -20οC for further use.  
3.3.4 Cloning of GEPI Gene with Linker into pMALc2X Expression Vector 
This section provides subcloning a gene of interest into a pMALc2X vector. This 
procedure provides that a fragment containing the gene of interest with a blunt end at 
the 5' end of the gene and an overhang at the 3' end to be inserted into the pMALc2X 
vector, using the restriction site adjacent to and downstream of the sequence 
encoding the protease site (the primary site), and a site further down in the polylinker 
with a compatible overhang. The DNA fragments were made by PCR After that, the 
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DNA fragments were digested with the suitable restricted endonucleases for 
construction a 5'-blunt 3'-sticky-ended fragment containing the gene of interest. The 
used restriction enzymes were shown in Figure 4.2, Figure 4.3, Figure 4.4, and 
Figure 4.5. The restriction site for creating the sticky end is one of the enzymes, PstI, 
which cuts in the pMALc2X polylinker downstream of the primary site. Later, the 
digest DNA inserts and digest vector were extracted from the gel. Cleaned and 
concentrated inserts were ligated with pMALc2X vector.  
3.3.4.1 Ligation 
The inserts digest and vector digest run onto agarose gel were isolated from LMP 
agarose gel and set up the following ligation reactions in Tablo-3.11, Tablo-3.12, 
Tablo-3.13 and Table 3.14. Using the equation (3-1), the volume of the vector 
component required in the ligation is calculated first, then this is subtracted from the 
total DNA component of the reaction (T) to give the required insert volume. The 
value T represents the combined volume of vector and inserts DNA solutions added 
to the ligation reaction. The lengths and concentrations of the DNA fragments must 
be inserted along with the desired insert-to-vector ratio. 
                              Vv = T
V   ∙   Iı  ∙  II  ∙  Vı  
              Iv = T  −   Vv                                       (3-1) 
Equation (3-1) described determination of the volumes required in a ligation 
reaction. Insert and vector parameters must both be in the same units (e.g. kilobases 
for length and micrograms per microlitre for concentration). Il Insert length, Vl vector 
length, Ic insert concentration, Vc vector concentration, Ir required insert-to-vector 
ratio, T volume of total DNA solution component, Vv vector volume, Iv insert 
volume. The Ir should be inserted as insert/vector (e.g. 2 for a two-fold insert excess, 
0.5 for a two-fold vector excess). 
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Component Volume 
pMALc2X vector digest (6611 bp,  143 ng/µl) 7,9 µl 
Insert digest ( 48 bp, 85 ng/µl)
 
2,1 µl 
2X Quick Ligation Buffer* 10 µl 
Quick T4 DNA Ligase 1,0 µl 
Total volume 21 µl 
*Quick LigationTM Buffer is supplied with Quick LigationTM Kit from New England Biolabs (Catalog # M2200S) 
Reaction condition 
Ligation reaction was incubated at room temperature (25 o C) for 1h and chilled on 
ice. 
Component Volum
e 
pMALc2X vector digest (6611 bp,  143 ng/µl) 6,9 µl 
Insert digest ( 54 bp, 58 ng/µl)
 
3,1 µl 
2X Quick Ligation Buffer* 10 µl 
Quick T4 DNA Ligase 1,0 µl 
Total volume 21 µl 
*Quick LigationTM Buffer is supplied with Quick LigationTM Kit from New England Biolabs (Catalog # M2200S) 
Reaction condition 
Ligation reaction was incubated at room temperature (25 o C) for 1h and chilled on 
ice.  
  
Table 3.11: Ligation reaction for SGGG-AuBP1 according to insert/vector ratio 
which is10 for a two-fold insert excess 
Table 3.12: : Ligation reaction for (PG)3-AuBP1 according to insert/vector ratio 
which is10 for a two-fold insert excess 
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Component Volume (µl) 
pMALc2X vector digest (6611 bp,  143 
ng/µl) 
3,5  
Insert digest ( 48 bp, 6 ng/µl)
 
6,5 
2X Quick Ligation Buffer* 10 
Quick T4 DNA Ligase 1,0  
Total volume 21  
*Quick LigationTM Buffer is supplied with Quick LigationTM Kit from New England Biolabs (Catalog # M2200S) 
Reaction condition 
Ligation reaction was incubated at room temperature (25 o C) for 1h and chilled on 
ice.   
3.3.4.2 Preparation of X-Gal/IPTG-Amp Plates 
50 µl Ampicillin solution and 200 µl X-Gal/IPTG solution made up of 20 mg/ml X-
Gal and 25mM IPTG were put into 50 ml liquid LB agar at 50 oC and was poured 
onto plastic sterile petri dishes, quickly. The final concentrations of X-Gal and IPTG 
on each plate should be 80 µg/ml X-Gal and 0.1 mM IPTG. 
  
Table 3.13: Ligation reaction for SGGG-QBP2 according to insert/vector ratio 
which is10 for a two-fold insert excess 
Table 3. 14: Ligation reaction for (PG)3-QBP2 according to insert/vector ratio which 
is10 for a ten-fold insert excess 
Component Volume  (µl) 
pMALc2X vector digest (6611 bp,  150 ng/µl) 8,6 
Insert digest ( 54 bp, 73 ng/µl)
 
1,4 
2X Quick Ligation Buffer* 10 
Quick T4 DNA Ligase 1,0 
Total volume 21 
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3.3.4.3  Chemical Transformation of Ligation Mixture into E.coli K12 TB1 
The ligation reaction was transformed into competent cell E. coli K12 TB1. The used 
protocol was as follows:  
1. The vial of TB1 chemically competent cells in microfuge tube is thawed on ice.  
2. 5 µl of ligation reaction is added into the vial of competent cells, mixed gently 
and incubated on ice for 40-60 minutes. 
3. The cells are heat shocked at 42o C for exactly 1-2 minutes without shaking. 
4. The tubes are immediately transferred to ice and are incubated on ice for 1 
minute 
5. 0.2 ml of room temperature SOC medium and 0.8 ml LB medium are added to 
the mixture of the ligation reaction and competent cells.  
6. The tubes are tightly capped and shacked horizontally at 200 rpm at 37o C for 4 
hours. 
7. 4 dilutions (75, 150, 200 and 250 µl) are spread from the transformation reaction 
onto pre-warmed LB agar plates with 100 µg/ml Ampicillin and LB agar plate 
containing 100 µg/ml Ampicillin, 80 µg/ml X-Gal and 0.1 mM IPTG by using a 
spreader. 
8. The plates are incubated at 37o C overnight. 
3.3.4.4 Colony Screening 
To select the recombinant colonies from LB Agar+ampicillin plates alpha 
complementation has been carried out. In α-complementation pMALc2X expression 
vector include partial lacZ gene. After ligation, the resulting DNA was used to 
transform E. coli K12 TB1 competent cells in which partial lacZ gene missing in the 
vector is present. In cells that contain a vector without an insert, the amino-terminal 
ß-galactosidase subunit would interact with the carboxyl-terminal ß-galactosidase 
subunit to form an active ß-galactosidase enzyme, which catalyzes formation of a 
blue colored product from colorless X-Gal in the presence of inducer IPTG making 
the non-recombinant cells blue. However, clones containing an insert, recombinants, 
would not produce a functional ß-galactosidase, and would consequently appear 
white in color [1-3]. Therefore, α-complementation was helped to impress if getting 
successful cloning and transformation. The colonies were picked with a sterile 
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toothpick and stabbed onto master LB amp plate and an LB plate containing 80 µg/ml 
Xgal and 0.1 mM IPTG. The plates were incubated at 37°C for 8 to 16 hours. The Lac phenotype on the X-
Gal plate determined and recovered the “white” clones from the corresponding patch 
on the master plate. In addition, there was a control transformation with about 1 ng of 
the uncut pMAL vector. Since most inserts prevent expression of any lacZα 
fragment, it is possible to get some α-fragment activity in clones with inserts. In this 
case, a difference in the shade of blue can usually be seen by comparing to 
transformants containing the vector alone. At the same time, an alternative way was 
used for the blue-white screen. The replica plate on LB amp and LB amp Xgal IPTG 
were prepared. The ligation mixture was divided into two aliquots, and one of them 
was spread on 80 µg/ml X-Gal, 0.1 mM IPTG to observe the percentage of clones 
with inserts. It was acceptably high; therefore the transformants were screened on the 
LB amp plate directly by preparing plasmid DNA. Because of the strength of the 
Ptac promoter, transformants taken from a plate containing IPTG can contain mutant 
plasmids that have either 1) lost part or the entire fusion gene, or 2) no longer express 
it at high levels [1-3]. 
3.3.4.5 Plasmid Isolation from Inoculated Transformant Cell 
vv Following transformation, the white colonies received the vector with inserts were 
chosen from master plates LB agar containing 100 µg/ml Ampicillin  and grown in 3 
ml liquid LB containing 100 µg/ml overnight. Plasmid DNA was isolated for DNA 
sequence analysis and further applications by using High Pure Plasmid Isolation Kit 
from Roche (Catalog # 1 754 785). Isolation procedure is described below: 
1. 3 ml of the culture is centrifuged 60 seconds at 6000 g. 
2. The supernatant is discarded. 
3. The pellet is resuspended in 250 µl Suspension Buffer + RNase. 
4. 250 µl Lysis Buffer is added, mixed gently by inverting the tube 3 to 6 times and 
incubated at 15-25 οC for 5 minutes. 
5. 350 µl chilled Binding Buffer is added mixed gently and incubated on ice for 5 
minutes. 
6. The samples are centrifuged at 13.000 g. for 10 minutes. 
7. High Pure Filter Tubes are interested into Collection Tubes. 
8. Supernatant is transferred to High Pure Filter Tube and centrifuged at 13.000 g. 
for 1 minute. 
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9. The flow-through is discarded. 
10. 500 µl Wash Buffer l is added and centrifuged at 13.000 g for 1 minute. 
11. The flow-through is discarded. 
12. 700 µl Wash Buffer II is added centrifuged at 13.000 g for 1 minute. 
The flow-through is discarded and an additional 1 minute centrifuged at 13.000 g. is 
done. 
13. The filter tube is placed in 1.5 ml microcentrifuge tube and 100 µl Elution 
Buffer is added. 
14. The isolated plasmid is checked by running on an agarose gel. 
3.3.4.6 Agarose Gel Electrophoresis of purified pMALc2X Constructs  
Agarose gel electrophoresis was applied for analyzing of plasmid. The agarose gel 
was 0.7 % because the plasmid size is over 6kb.  Lambda DNA/EcoRI+HindIII 
Marker 3, purchased from Fermentas (Catalog #SM0193) in Appendix C was used as 
a marker. 
3.3.4.7 Analyzing Transformants 
The plasmids were analyzed by restriction analysis to confirm the presence and 
correct orientation of the insert. Firstly, the restriction enzymes and a combination of 
enzymes that cut in the vector and the insert were tested both by computer program 
named pDRAW32 to predict the size of the fragments and inserts After that, the 
result from agarose gel electrophoresis experiment was compared with that of 
computer program. 
3.3.4.8 DNA Sequence Analysis  
 To confirm that the gene is cloned in the correct orientation the constructs were 
sequenced as well as restriction analysis Considering the results from restriction 
analysis the plasmids were sequenced by the help of ABI PRISM 3100-Avant 
Genetic Analyzer (PE, Applied Biosystem, CA) using Big Dye® Terminator V 3.1 
cycle sequencing kit from Applied Biosystems with the procedure given in Table 
3.15. 
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Component Volume 
Template  2,5µl  
M13 -40 primer (3.2 pmole) 1µl 
5X Sequencing Buffer 1 µl 
Big Dye Terminator 2 µl 
Distilled water 3,5 µl 
Total Volume 10 µl 
The reaction tubes were mixed well and spin briefly. The sequence PCR was 
performed according to Table 3.16 
Temperature(○C) Time Cycles 
95 5 min 1 
95 1 min  
30 50 30sec 
60 4 min  
4 ∞  
3.3.4.9 NaAc-Ethanol Precipitation (Purification) of PCR Products 
To obtain clean sequencing data, Ethanol/Sodium Acetate Precipitation method 
given in below was used after PCR. Then the samples were sequenced by ABI 
PRISM 3100-Avant Genetic Analyzer (PE, Applied Biosystem, CA). 
1. 1 µl 3M pH 4.6 sodium acetate (cold) and 25 µl 95 % ethanol (cold) are mixed 
for each sample. 
2. 26 µl mixture is added into each PCR product and samples are incubated on ice 
for 15 min. 
3. After incubation, samples are centrifuged for 15 min. at 13000 rpm. 
Table 3.15: Preparation of cycle sequencing reaction
Table 3.16: Sequence PCR Conditions
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4. Supernatant is discarded and DNA pellet is washed with 250 µl cold 70% 
ethanol. 
5. Samples are centrifuged for 15 min. at 13000 rpm. 
6. Ethanol is discarded; the residual ethanol is evaporated by incubating at 95οC. 
7. DNA pellet is dissolved in 20 µl formamide. 
8. Samples are denatured by putting at 95oC for 3 minutes and then at -20oC for 5 
min. 
3.3.4.10 Sequence Alignment 
 EMBOSS Pairwise Alignment Algorithms tool was used to compare 2 sequences. 
The water local alignment method of Smith-Waterman was used for trying to find the 
best region of similarity between two sequences. The glycerol stocks of the cells 
received the correct genes were prepared. 
3.3.4.11 Transformation of pMAL c2X with Insert into E.coli K12 ER2507 
The plasmids confirmed sequence was transformed into competent cell E. coli K12 
ER2507 for correct expression and their glycerol stocks were prepared as in 3.3.3.1. 
The expression available host strains used in this study is TB1 and ER2507 K12 E. 
coli strains. The most important property of these strains is their capability of MBP 
and MBP-fusion protein expression rare tRNAs that are found in E. coli. TB1 strain 
is a derivative of JM83 that has been made hsdR so it will not restrict unmodified 
DNA. It has lacZ∆M15 allele that’s why it is proper for α-complementation. ER2507 
is a derivative of RR1. The malE gene, which encodes maltose-binding protein, is 
deleted as part of the malB deletion. The malE gene is included in the malB deletion, 
so this strain does not make any MBP from the chromosome. It does not have the 
lacZ∆M15 allele, so it cannot be used for α-complementation (no blue-to-white 
screen on Xgal). This strain can be transformed with high efficiency, similar to RR1 
and HB101. 
The used protocol of chemical transformation was as follows:  
1. The vial of ER2507 chemically competent cells in microfuge tube is thawed on 
ice.  
2. 0.1-0.5 µl of vector with insert is added into the vial of competent cells, mixed 
gently and incubated on ice for 30 minutes. 
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3. The cells are heat shocked at 42o C for exactly 60 seconds without shaking. 
4. The tubes are immediately transferred to ice and are incubated on ice for 10 
minutes. 
5. 0.2 ml of room temperature SOC medium and 0.8 ml LB medium are added to 
the mixture of vector and competent cells in the microfuge tube  
6. The tubes are tightly capped and shacked horizontally at 200 rpm at 37o C for 15 
minutes. 
7. 4 dilutions (25, 50, 75 and 150 µl) are spread from the transformation reaction 
onto pre-warmed LB agar plates containing Ampicillin by using a spreader. 
8. The plates are incubated at 37o C overnight. 
3.3.5 Protein Expression Studies 
3.3.5.1 Pilot Experiment 
Following construction of the vector for the bi-functional protein, the pilot 
experiment, a small scale experiment, was carried out for determination the behavior 
of a particular MBP fusion protein and the optimization of the protein expression and 
purification. This protocol results in five pMALc2X vectors samples are uninduced 
and induced cells, a total cell crude extract, a suspension of the insoluble material 
from the crude extract, a fraction containing protein that binds to the amylose resin. 
In the expression step, a single colony which harbors only 
pMALc2X_SGGG_AuBP1, pMALc2X_(PG)3_AuBP1, pMALc2X_SGGG_QBP2 
and pMALc2X_(PG)3_QBP2 from each LB agar plate of ER2507 strain was picked 
by a sterile toothpick and grown in 5 ml LB containing Ampicillin of 100 g/ml 
overnight to analyze the target protein production. Then, the below protocol was 
followed. 
The protocol is as follows: 
1. 80 ml rich broth which is LB containing Ampicillin of 100 µg/ml, 2 %  glucose 
with 0.8 ml of an overnight culture of cells containing the fusion plasmid is 
inoculated.  
2. The bacterial culture is grown on shaker at 200 rpm at 37°C until optical density 
A600 is ~0.5. A sample of 1 ml is taken and centrifuged for 2 minutes (sample 1: 
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uninduced cells). Supernatant is discarded and the cells are resuspended in 50 µl 
2X SDS-PAGE Sample Buffer by vortex and frozen at –20°C. 
3. IPTG is added as to the remaining culture to a final concentration of 0.3 mM, e.g. 
0.24 ml of a 0.1 M stock in H2O Incubation is continued at 37°C for 4 hours. A 
0.5 ml sample is withdrawn and centrifuged for two minute (sample 2: induced 
cells). Supernatant is discarded and the cells were resuspended in 100 µl 2X 
SDS-PAGE Sample Buffer by vortex and frozen at –20°C.  Additional time 
points at 1 and 4 hours is helpful in trying to decide when to harvest the cells for 
large scale preparations. 
4. The cells harvested by centrifugation at 4000 x g for 10 minutes. The supernatant 
is discarded. 
5. The pellet is frozen overnight at –20°C. The freeze one pellet is resuspended in 5 
ml of Column Buffer and thawed in cold water. 
6. The cells were placed on ice and sonicated in short pulses of 10 seconds. The 
release of protein is monitored using the Bradford assay Monitor (21), adding 10 
µl of sonicated sample to 1.5 ml Bradford reagent and mixing. Sonication is gone 
on until the released protein reaches a maximum (usually about 2 minutes). 
7. The sonicated cells are centrifuged at 9,000 x g at 4°C for 20 minutes. The 
supernatant (crude extract) is decanted and saved on ice. The pellet is 
resuspended in 5 ml Column Buffer. This is a suspension of the insoluble matter. 
5 µl of 2x SDS-PAGE Sample Buffer is added to 5 µl of the crude extract and 
insoluble matter fractions (samples 3 and 4, respectively).  
8. ~200 µl of the amylose resin is placed in a microfuge tube and spun briefly in a 
microcentrifuge. The supernatant is removed by aspiration and discarded. The 
resin is resuspended in 1.5 ml Column Buffer, then centrifuged briefly and the 
supernatant is discarded.  Again the resin is resuspended in 200 µl of Column 
Buffer. 50 µl of crude extract is mixed with 50 µl of the amylose resin slurry. 
Mixture is incubated for 15 minutes on ice and centrifuged for 1 minute, then the 
supernatant is removed and discarded. The pellet is washed with 1 ml Column 
Buffer, centrifuged for 1 minute, and the resin is resuspended in 50 µl SDS-
PAGE Sample Buffer (sample 5: protein bound to amylose). 
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3.3.5.2 Cell Fraction Analysis  
Following induction  the samples 1,2,3,4 and 5 obtaining from in step 2,3,7 and 8 in 
the above-mentioned protocol were analyzed via SDS PAGE and Bradford assay  in 
3.3.5.3. The procedure was explained in the SDS-PAGE methodology section 
3.3.5.4.  
3.3.5.2 Bradford Protein Determination Assay 
Protein concentration was determined according to Bradford Assay to assess the 
sonication efficiency and to calculate the fusion protein amount in total cell protein. 
Bradford reagent was purchased from Sigma. (Catalog # B 6916) Bovine serum 
albumin (Sigma) was used as standard. 
3.3.5.3 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) was 
performed essentially as described by Laemmli et al., 1970) using vertical gel 
electrophoresis system.   Proteins were resolved on 10 -12 % (w/v) acrylamide slab 
gels in the presence of 0.1 % SDS. Proteins were dyed with CBB-R250 or CBB-G25.  
Proteins were stained for 30 minutes in the stain solution at room temperature on 
rocker at 15.000 rpm. They were destained in destain solution for overnight on 
rocker at 15 rpm in room temperature. 30% acrylamide mix was prepared by 
dissolving acrylamide and N,N'-Methylenebisacrylamide in ddH2O, the mixture was 
then filtered through 0,45 µm cellulose acetate membrane filter.  
Solutions for preparing resolving gels for SDS-PAGE: 
All the solutions in Table 3.17 were mixed to prepare %10 or %12 resolving gels for 
SDS-PAGE. 
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Components Amount (ml) 
Concentration of acrylamide mix 10 % 12 % 
dH2O 4.79  4.29  
40 %  acrylamide mix 2.5 3.0  
1.5M Tris (Hydroxymethyl) aminomethane (Tris) (pH 
8.8) 
2.5  2.5  
20 %  Sodium n-Dodecyl Sulfate (SDS) 0.10 0.10  
10% AMPS 0.10  0.10  
N,N,N',N'-Tetraethyl ethylenediamine (TEMED) 0.01  0.01  
Total 10 10  
Solutions for %5 stacking gels for SDS-PAGE: 
All solutions given in Table 3.18 were mixed to prepare %5 Stacking Gels for 
SDSPAGE. 
Components Amount (ml) 
dH2O 3.94 
40% acrylamide mix (g/ml) 0.50 
1M Tris pH 6.8 0.50 
20% SDS 0.030 
10% AMPS 0.030 
TEMED 0.003 
Total 4.0 
 
  
Table 3.17: Ingredients of separating gel for SDS-PAGE.
Table 3.18:  Ingredients of 5 % stacking gels for SDS-PAGE
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CBB -R250 or CBB-G250 stain solution: 
All  ingredients in Table 3.19 were mixed and then filtered through chromatography 
paper. 
Components Amount (ml) 
dH2O 650  
Isopropanol 250  
Acetic acid glacial 100  
CBB-R250  2.5 g 
Total 1000 
Destain solution: 
All the ingredients in Table 3.20 were mixed to form the destain solution. 
Components Amount 
(ml) 
dH2O 650 
Methanol 100 
Acetic acid glacial 50 
Ethanol 200 
Total 1000 
3.3.5.4 Large Scale Protein Expression and Purification 
The method used in this study was designed for purification of a soluble fusion 
protein expressed in the cytoplasm from a pMALc2X vector. The method is as 
follows: 
1. 1 L rich broth containing 2% glucose and Ampicillin of 100 µg/ml with 10 ml of 
an overnight culture of cells containing the fusion plasmid is inoculated. 
Table 3.19: Ingredients of CBB -R250 or CBB-G250 stain solution.
Table 3.20: Ingredients of destain solution.
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2. The cells are grown for 3 hours until to reach 0.5 of OD600, 2 x 108 cells/ml. 
IPTG is added to a final concentration of 0.3 mM, e.g., 85 mg or 3 ml of a 0.1 M 
stock in H2O. The cells are incubated at 37oC for 3 h. 
3. The cells are harvested by centrifugation at 4000 x g for 20 min and the 
supernatant is discarded. The cells are frozen overnight at –20 oC and thaw on 
ice.  
4. The cells are resuspended with 50 ml column buffer containing 2-
mercaptoethanol. 
5. Sample is placed on ice sonicated in short pulses of 10 s and 10 s stop in 1.5 
minutes.  
6. Sonicated sample is centrifuged at 9,000 x g for 30 minutes and the supernatant 
called crude extract as well is saved. The crude extract is diluted 1:4 with column 
buffer. 
7. Considering the total cell protein analysis the amylose resin column is packed. 
The column is washed with 8 column volumes of column buffer. 
8. The diluted crude extract is loaded at a flow rate of 1 ml/min for a 2.5 cm 
column. 
9. The loaded column is washed with 12 column volumes of column buffer  
10. The fusion protein is eluted with elution buffer which consists of column buffer 
and 10 mM maltose. 10–20 fractions of 3 ml each is collected. The fusion protein 
usually starts to elute within the first 10 fractions, and the fractions are detected 
by UV absorbance at 280 nm and checked by SDS PAGE. 
11. The protein containing fractions are pooled and concentrated in an Amicon® 
Ultra-15 Centrifugal Filter with 30,000 NMWL membrane (Milipore, Catalog # 
UFC9 030 24). The buffer of protein is changed with water and protein in water 
is lyophilized for long storage and further applications. 
3.3.5.5 MALDI-TOF Mass Spectrometry 
 In order to confirm the purity and identity of the individually expressed proteins, 
Mass spectrometry (MS) was performed with the purified wt MBP, and the MBP-
GEPI fusion proteins. Desalted samples were diluted in a matrix solution; 5mg/ml 
sinapinic acid (SA) (Sigma) in water: acetonitril solution (50%:50% vol:vol) and 
spotted onto the MALDI sample plate with 2µl/well to obtain strong signal. Droplets 
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were dried and then placed into mass spectrometer. The most intense peaks match 
expected m/z values for singly charged species for the individual proteins. 
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oligonucleotide (in Figure 4.3) has the same properties like that of SSSG-AuBP1. 
The major differences between the sequences of these oligonucleotides are the GEPI 
sequence in base and reverse primer binding site because of the different GEPI used 
at the 3’end. 
5’ - TAT ATA TTT GGA TCC GGC GGC GGC -3’ 
5' - TAT ATA TTT GGA^TCC GGC GGC GGC TGG GCG GGC GCG AAA CGT  
                                    NIaIV 
                                                            Stop           Pst I 
CTG GTG CTG CGT CGT GAA TAA TAA CTG CA^G CGC CCG CGC -3' 
                                     3’- CTT ATT ATT GAC GTC^ GCG GGC GCG -5 
Figure 4.2: The sequence of SGGG-AuBP1 oligonucleotide and primer binding site 
The oligonucleotide sequences of (PG)3-AuBP1 and (PG)3-QBP2 genes are shown in  
Figure 4.4 and Figure 4.5 respectively. The used restriction enzymes are MscI caused 
the blunt end at 5’end and PstI for sticky end at 3’ in the sequence designed of 87 bp. 
At the 3’end, two stop codons (TAATAA) exist. GEPI sequence and reverse primer 
binding site are different in each oligonucleotide.  
5’- TAT ATA TTT GGA TCC GGC GGC GGC -3’ 
5'- TAT ATA TTT GGA^TCC GGC  GGC  GGC CTG CCG GAT TGG TGG CCG  
                                    NIaIV 
                                                            Stop           Pst I 
CCG CCG CAG CTG TAT CAT TAA TAA CTG CA^G CGC CCG CGC -3' 
                                  3’- GTA  ATT  ATT  GAC  GTC  GCG GGC GCG-5’ 
Figure 4.3: The sequence of SGGG-QBP2 oligonucleotide and primer binding site 
The forward and reverse primers were used for the amplification of the sequence and 
at the end of the reaction a double stranded Linker-GEPI DNA with restriction sites 
was obtained from a single stranded oligonucleotide. The result of  the PCR product 
is analyzed by agarose gel electrophoresis (Figure 4.1). 
5’- TAT ATA TTT TGG  CCA GGC CCG GGC -3’ 
5'- TAT ATA TTT TGG^CCA GGC CCG GGC CCG GGC  TGG GCG GGC GCG AAA  
                                  MscI 
                                                                        Stop          Pst I 
CGT CTG GTG CTG CGT CGT GAA TAA TAA CTG CA^G CGC CCG CGC -3' 
                                                  3’-CTT ATT ATT  GAC  GTC   GCG GGC GCG-5’ 
Figure 4.4: The sequence of (PG)3-AuBP1 oligonucleotide and primer binding site 
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In the oligonucleotides, the sequences of the individual single gold binder region and 
quartz binder region were placed, following the linker region. Stop codons were 
placed to the end of the so- called binder regions. The restriction sites introduced to 
the sequence were selected as cloning strategy. 
In designing  the oligonucleotide of individual GEPI with linker, the sequence of the 
gold or quartz binder region are designed to have stop codons before the PstI 
restriction site which forms sticky end, and a few random bases for primer binding 
site to perform PCR successfully. In the beginning of sequence, there is a linker 
region which is either flexible, SGGG, or, rigid linker, PGPGPG. Following the 
linker region, a few random bases and a restriction site, which can be used for 
formation of blunt end, exist. The used restriction enzymes for blunt end formation 
are MscI at SGGG linker and N1a1V at PGPGPG linker. 
5’- TAT ATA TTT TGG CCA GGC CCG GGC -3’ 
5'- TAT ATA TTT TGG^CCA GGC CCG GGC CCG GGC CTG CCG GAT TGG  
                                    MscI   
                                                                       Stop         Pst I 
TGG CCG CCG CCG CAG CTG TAT CAT TAA TAA CTG CA^G CGC CCG CGC-3' 
                                            3-’GTA ATT ATT  GAC GTC GCG GGC GCG-5’ 
Figure 4.5: The sequence of (PG)3-QBP2 oligonucleotide and primer binding site 
The strategy for the construction of the bi functional protein was developed a method 
to ligate the desired domain. For this ligation, two different restriction sites placed in 
the multiple cloning site of the pMALc2x vector, were chosen (Figure 4.6). In 
addition, two other different restriction sites were preferred considering the linkers 
sequences. XmnI and PstI were selected for vector digestion. Here, the reason for 
choosing XmnI site was due to formation of the blunt end, and its protein cloning 
site. XmnI nucleotide recognition site in pMALc2X vector is G GAAGG^ATTTC 
which can be expressed as Glycine (Gly) and Arginine (Arg), respectively. The 
pMALc2X vector also contains the sequence coding for the recognition site of a 
specific protease, located just 5´ to the polylinker insertion sites. This allows MBP to 
be cleaved from the protein of interest following the purification. The pMALc2X 
vector that is included in the system encode the site for Factor Xa. Factor Xa cleaves 
after its four amino acid recognition sequence, Isoleusine (Ile), Glutamine (Glu), 
Glycine (Gly) and Arginine (Arg), so that few or no vector-derived residues are 
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attached to the protein of interest, depending on the site used for cloning. MscI 
enzyme was selected since it can form blunt end following the digestion. It has 
TGG^CCA recognition site. The following the digestion remained CCA is expressed 
as Serine (Ser) that is the first amino acid of flexible linker, SGGG-. For the first 
amino acid of PGPGPG- peptide linker expression N1aIV restriction enzyme was 
used. Its recognition site is GGN^GCC and following the digestion GCC in linker 
region is expressed as Proline (Pro). 
LacI Promotor
LacI Start Codon
Ptac Promotor
MalE Start Codon
Maltose Binding Protein
XmnI
Protease Site
Linker-GEPI
PstILacZ- Start Sequenceα
LacZ-α
M13 Origin
PBR322
pMALc2X-LinkerGEPI
   vector 6670 bp
 
Figure 4.6: Schematic diagram of constructed recombinant plasmid pMALc2X-
Linker-GEPI carrying maltose binding protein at its N-terminus for 
overexpression of recombinant MBP-GEPI bifunctional protein. 
After ligation of the purified amplified fragment and linearized pMALc2X 
transformation of TB1 cells was carried out. Since the restriction sites between malE 
and lacZα are available for inserting the coding sequence of interest insertion 
inactivates the β-galactosidase α-fragment activity of the malE-lacZα fusion. This 
activity results in a blue to white color change on X-Gal plates when the construction 
is transformed into α-complementing host such as TB1 or JM107. Moreover, it has 
given the best results when considering plasmid stability, expression and 
purification. Individual colonies were screened for the insert by duplicate streaking 
on LB amp plates with and without IPTG and X-Gal since putative recombinant 
  
clones do not form blue colonies on the LB amp broth with IPTG and 
Recombinant vectors were electrophored for checking size (
Figure 4.7: (A) The recombinant and non
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Lane 1 is pMALc2X
We also used another strain in response to a particular problem which is expression.
Therefore, transformation of ER2507 was carried out after the recombinant DNA 
sequence was assessed. Then the nucleotide sequence of recombinant clones was 
confirmed as the correct one so that the protein production was preceded. ER2507 
was used since the malE gene is included in the 
from the chromosome. It does not have the 
α-complementation (no blue
important to try different combinations of target protein and bacterial
the complicated renaturation.
4.2. Expression Studies
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Figure 4.8:  Effect of induction time on the expression of MBP
protein. Aliquots of 1000 µl were taken from cultures induced with 0.3 
mM IPTG every hour up to 4 h.
rpm for 2 minutes and pellets were subjected to SDS
detection of fusion protein. M is
To release the fusion protein from cells, the combination of three procedures were 
performed, including the addition of 50 mg lysozyme/ml, sonication and freezing. 
All methods included the addition to the column buffer of 10 mM 2
to prevent interchain disulfide bond formation and protease
prevent digestion of the fusion protein
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sonicated until protein release was constant. As the lysate was clarified by 
centrifugation, the soluble protein fraction was
4.3 Purification Analysis 
In the pilot experiments, we first carried out optimization studies 
determination of the amount of amylose resin, size of column and the ingredien
column and elution buffer to ob
necessary, since  MBP fusion protein might not stick to the amylose column 
efficiently due to certain  factors 
a low intrinsic affinity. Factors in th
and cellular components are released during alternative methods of lysis 
(lysozyme/sonication). In addition, cells grown in LB have substantial amounts of an 
 
-GEPI bi-functional
 Samples were  centrifuged at 13 000 
-PAGE for the 
 marker. 
-mercaptoethanol 
-inhibiting cocktail to 
 through proteolitic activity. The best results 
-20 ο C, thawed, lysozyme addition and 
 subjected to affinity chromatography.
such as 
tain high yield purification. The optimization is 
in the extracts that interfere with binding, or present
e crude extract that can interfere with binding 
 
 
ts of 
 
  
61
amylase that interferes with binding. By including glucose in the media, expression 
of this amylase is repressed and the problem is alleviated. A low intrinsic affinity 
could be caused by an interaction between the protein of interest and MBP that either 
blocks or distorts the maltose-binding site. 
The most important variable in determining the useful life of the amylose resin is the 
amount of time that it is in contact with trace amounts of amylase present in the 
crude extract. Under normal conditions (crude extract from 1 liter of cells grown in 
LB + 0.2% glucose, 15 ml column), the column loses 1–3% of its initial binding 
capacity in each time it is used. If the yield of fusion protein under these conditions is 
40 mg, this means that after 3 to 5 runs there would be a decrease in the yield.  
The purification process of both wt-MBP and MBP-GEPI was performed using a 
modified New England Biolabs protocol. The first modification was addition of 
protease inhibitors to inhibit the undesired proteases. The second one was the use of 
β-mercaptoethanol of 1mM, which is 10-fold less than the standard procedure to 
prevent interchain disulfide bond formation upon lysis. Consequently, proteins were 
eluted from the cross-linked amylose column with a buffer containing 10mM maltose 
without reducing agent. 
The elution profile of the fusion protein from an amylose affinity chromatography 
column is shown in Figure 4.9 and Figure 4.10. The pooled fractions containing 
protein were either subject to SDS-PAGE and stained with Coomassie reagent 
(Figure 4.10 and Figure 4.11). The apparent molecular mass of the fusion proteins is 
~45 kDa which approaches the theoretical ones. The molecular mass of individual bi-
functional proteins is given in Table 4.1. Moreover, wt MBP has an electrophoretic 
mobility of 42.5 kDa in Figure 4.10, being the expected mass 42.481 kDa. 
  
62
 
Figure 4.9: Schematic of Purification of bi-functional proteins 
 
 
Figure 4.10: Elution profile from the amylose resin column. Purification of the 
MBP-GEPI bi-functional protein by affinity chromatography. 
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Figure 4.11: Electrophoretical mobility of the expressed and purified fusion 
proteins. Molecular weight marker is meant M. Lane 1is uninduced 
cell, Lane 2 is crude extract, lane 3 is last flow through, lane 4 is first 
wash, lane 5 is last wash, lane 6, 8  eluents whic
proteins. 
Figure 4.12: 5-110% SDS
extract, lane 3: fraction obtained from the last washing step, lane 3: 
fraction from the first elution step, lane 4: fraction from the second 
elution step, lane 5: fraction from the third elution step and lane 6: 
h are MBP fusion 
-PAGE result. Lane 1: Broad Range Marker, lane 2: crude 
fraction from the fourth elution step 
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4.4. Molecular Characterization by Mass Spectrometry 
In order to confirm the purity, identity and digestion reaction of the individually 
expressed proteins, we performed mass spectrometry (MS) with the purified wt 
MBP, and the MBP-GEPI bi-functional proteins. Desalted samples were diluted in a 
matrix solution, 5mg/ml sinapinic acid (SA) (Sigma) in water: acetonitril solution 
(50%:50% vol:vol) and spotted onto the MALDI sample plate with 2µl/well to obtain 
strong signal. Droplets were dried and then placed into mass spectrometer. The 
spectra for proteins MBP and MBP-GEPI are shown in Figure, respectively. As can 
be seen, the most intense peaks match expected m/z values for singly charged species 
for the individual proteins. The measured and predicted molecular masses are given 
in Table 4.1  
Constructs 
Yield of Total 
Protein 
Yield of 
Fusion 
Protein 
Apparent 
Molecular 
Weight 
Measured 
Molecular 
Weight 
wt MBP 180  mg/L culture 
40 mg/L 
culture 42.481 kDa 42.492 kDa 
MBP-PGPGPG-
AuBP1 150 mg/L culture 
41mg/L 
culture 44.381 kDa 44.470 kDa 
MBP-SGGG-AuBP1 85 mg/L culture 
37 mg/l 
culture 44.176 kDa 44.200 kDa 
MBP-PGPGPG-
QBP2 90 mg/L culture 
30 mg/L 
culture 44.475 kDa 44.600 kDa 
MBP-SGGG-QBP2 150 mg/L culture 
60 mg/L 
culture 44.270 kDa  44.247 kDa  
The mass spectrums of the wt MBP and wt MBP cleaved by FactorXa and  two main 
peaks were shown like  42 492 Da assigned to  cleaved wt MBP (predicted molecular 
mass: 42 481 Da)  and 43 301 Da assigned to wt MBP before cleavage. As 
mentioned wt MBP has a sequence of amino acids after protease site which is IEGR 
site. Therefore, purified wt MBP was digested by FactorXa to remove the residue the 
following protease site. 
  
Table 4.1: The apparent and measured molecular weight of bi-functional proteins
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The major aim of this study, was to construct and purify maltose binding protein 
fused with a inorganic binding peptide thorough a linker. To demonstrate this, we 
have chosen two different inorganic binding peptides, a first generation cell surface 
displayed selected gold binding peptide, AuBP1(MW: 1454.7, WAGAKRLVLRRE) 
and a second generation designed de novo quartz binding peptide, QBP2 ( MW: 
1549, LPDWWPPPQLYH). Those two peptides were genetically fused into maltose 
binding protein through two different linkers, rigid (PG)3 and a flexible S(G)3. Each 
of the linkers were inserted to the beginning of the GEPI region. The expressed 
fusion protein with GEPI was designated as MBP-GEPI in the pMALc2x plasmid. 
The GEPI gene in the pMALc2x is connected with the peptide linker. The presence 
of a linker between MBP and GEPI was chosen to obtain sufficient flexibility to 
adopt optimal binding orientations. Therefore, the linker should be as rigid as 
possible in order to perform the bioactive conformation of the compound and to 
reduce the entropic cost of binding.  
The four constructs have been generated by cloning the individual AuBP1 and QBP2 
inorganic binding peptides in pMALc2X. The conditions to express these constructs 
in E.coli  have been optimized. The desired bi-functional proteins have been then 
isolated by affinity chromatography. In order to obtain Wt MBP, cleaved extra amino 
acid residue has been separated by affinity chromatography. All steps along the 
process of production, cleavage and purification were checked by SDS-PAGE. The 
amount of soluble bi-functional proteins obtained from 1L culture are shown in 
Table 4.1. The purity and molecular weight of expressed and purified proteins were 
checked using mass spectrometry. The measured mass was shown to correspond to 
the expected molecular weight of each bi-functional proteins having MBP and 
corresponding inorganic binding peptide. 
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Maltose binding protein is a membrane protein used in the transportation of the 
maltose form the outer membrane space into the cell. However, it is also used as a 
tag  protein in protein purification, as it enhances the solubility of the proteins, and 
also used as a biosensor agent towards detection of some sugars as well as a photonic 
based detection system. Here, we designed bi-functional proteins using specific 
GEPIs cloned into MBP that would lead to the peptide-directed immobilization of 
various nanostructures or molecules onto different multimaterial patterned surfaces. 
We believe that a novel alternative to current chemical coupling may be the utility of 
combinatorially-selected inorganic-binding peptides as molecular linkers. Moreover 
using various specific inorganic-binding peptides as molecular coupling linkers 
would potentially enable the simultaneous immobilization of multiple functional 
molecules/nanostructures on one multimaterial array device. Therefore, in future 
studies, we will demonstrate the MBP-GEPI fusion proteins used as patterning 
substrates and demonstrate their sensing abilities via different methods. We also plan 
to characterize their binding kinetics and thermodynamics using Surface Plasmon 
Resonance (SPR) and Quartz Crystal Microbalance (QCM). 
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Appendix A 
Vector Map of pMAL 
 
Features: 
15-46        lacI promoter 
1406-1433      Ptac promoter 
1478           Begin malE DNA fragment 
1528           malE start codon (ATG) 
2629           Start polylinker, factor Xa site 
2735           Start lacZ-alpha sequence (CA CTG GCC) 
2914           First in-frame stop codon for lacZ-alpha 
3327           Start pBR322 sequence 
3418           beta-lactamase (Amp-r) start codon (ATG) 
4276           beta-lactamase termination codon (TAA) 
4320-4833     M13 origin (+ -) 
4944-5532      pBR322 origin 
6646           End 
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DNA Molecular Weight Markers
a) Lambda DNA/EcoRI+HindIII 
length gel, 1X TAE, 17V/cm. (Catalog 
 
b) Lambda DNA/Eco130I (StyI) Marker 16, 1.0% agarose, 0.5 µg/lane, 8 cm 
length gel, 1X TAE, 17V/cm. (Catalog # SM0161, Fermentas)
 
c) PhiX174 DNA/BsuRI (HaeIII) Marker 9, 1.7% agarose, 0.5 µg/lane, 8 cm 
length gel, 1X TBE, 17V/cm. (Catalog #SM0252, Fermentas)
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Marker 3, 1.0% agarose, 0.5 µg/lane, 8 cm 
#SM0193, Fermentas)   
 
 
 
  
Protein Molecular Weight Markers
a) Protein Marker, Broad Range (2
with known amino acid sequences. Th
analyzed by SDS
250. Two bands (BSA, MW 66.4 kDa and Triosephosphate isomerase, 
MW 26.6 kDa) are at double intensity to serve as reference points.
#P7702S, New England Biolabs) 
 
b) The Unstained Protein Molecular Weight Marker is designed for precise 
sizing of proteins by SDS
of 7 proteins (14.4
polyacrylamide gel electrophoresis (Catalog # SM0431, Fermentas)
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-212 kDa)  is a mixture of purified proteins 
ey are resolved to 13 sharp bands when 
-PAGE (Tris-Glycine) and stained with Coomassie Blue R
 
-polyacrylamide gel electrophoresis. It is a mixture 
-116 kDa ) which appear as sharp bands after SDS
 
 
-
 (Catalog 
-
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Lab Equipments 
Autoclave                                                  : 2540 ML benchtop autoclave, Systec          
   GmbH Labor- Systemtechnik 
 : NuveOt 4060 vertical steam sterilizer,       
Nuve. 
Centrifuges      : Avanti J-30I, Beckman Coulter. 
   : Microfuge 18, Beckman Coulter. 
Centrifuge rotors     : JA30.50.Ti, Beckman Coulter. 
   : F421.5P, Beckman Coulter. 
Deep freezes and refrigerators : Heto Polar Bear 4410 ultra freezer,    
JOUAN Nordic A/S, catalog# 003431       
: 2021 D deep freezer, Arcelik. 
 : 1061 M refrigerator, Arcelik. 
Electrophoresis equipments :E-C Mini Cell Primo Ec320, E-C 
Apparatus. 
 :Mini-POROTEAN 3 Cell and Single-
Row AnyGel Stand, Catalog# 165-
3321, Bio-Rad. 
 :Mini-V 8.10 Vertical Gel 
Electrophoresis System, Lifw 
Technologies GibcoBrl (now 
Invitrogen), Catalog# 21078. 
Gel documentation system   : UVIpro GAS7000, UVItec Limited. 
Ice Machine     : AF 10, Scotsman. 
Incubators  : EN400, Nuve. 
Magnetic stirrer    : AGE 10.0164, VELP Scientifica srl. 
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 :ARE 10.0162, VELP Scientifica srl. 
Mass Spectrometry    : MALDI-TOF, Bruker 
Orbital shaker :Certomat S II, product# 886 252 4, B. 
Braun Biotech International GmbH. 
Pipettes     : Pipetteman P10, Eppendorf. 
pH meter     : MP 220  
  
  
78
  
  
79
Name Surname: Banu TAKTAK  
Place and date of birth: Eğirdir / January 29, 1982
 
Permanent Address: İTÜ Ayazağa Kampüsü Fen Edebiyat Fakültesi Moleküler 
Biyoloji ve Genetik Bölümü 34469 Maslak-Istanbul
 
Universities and Colleges attended:  
Istanbul, Istanbul Technical University, Advanced Technologies 
Molecular Biology-Genetics and Biotechnology Program, M.sc,   
2006-present  
 
Seattle, WA, University of Washington, Materials Science and 
Engineering, Visiting Graduate, 2007  
 
İzmir, Aegean University, Science Faculty, Biochemistry 
Department, B.sc, 2000-2005 
 
Publications  
   
Hnilova, M. , Taktak, B. ,  Carol, J. , Park. J. , So. C. , Ören. E. ,  
Sarıkaya, M. , Tamerler, C. 2008. “ Targeted Immobilization of 
Nanostructures and Biomolecules via Peptide Based Biolinkers 
Towards Nanosensing Platforms” Molecular Biomimetics and 
Bionanotechnology-3, Friday Harbor WA, USA 
 
Rutherford, M. , Kaçar, T. , Taktak, B. ,  So. C. Sarıkaya, M. , 
Tamerler, C. 2008. “ LSPR Based Anti-Maltose Binding Detection 
Using Genetically Engineered Molecular Construct and Peptide” 
Molecular Biomimetics and Bionanotechnology-3, Friday Harbor 
WA, USA 
 
Hnilova, M. , Taktak, B. ,  Carol, J. , Park. J. , So. C. , Ören. E. ,  
Sarıkaya, M. , Tamerler, C. 2009. “ Targeted Immobilization of 
Nanostructures and Biomolecules via Peptide Based Biolinkers 
Towards Nanosensing Platforms” Molecular Biomimetics and 
Bionanotechnology-3, MRS Spring Meeeting (will be presented) 
 
Taktak, B., Hnilova, M. , Sahin, D., Ören. E. , Sarıkaya, M. , 
Tamerler, C. 2008. “ Genetic Expression of Bi-functional Inorganic 
Binding  Peptides”, Molecular Biomimetics and Bionanotechnology-
3, Friday Harbor WA, USA 
CURRICULUM VITAE 
